"Drug Name","Active Ingredient","Form;Route","Appl. No.","Company","Date","Link"
"Abilify","Aripiprazole","TABLET, ORALLY DISINTEGRATING;ORAL","021729","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","TABLET;ORAL","021436","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf#page=84"
"Abilify","Aripiprazole","SOLUTION;ORAL","021713","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf#page=84"
"Abilify","Aripiprazole","SOLUTION;ORAL","021713","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","INJECTABLE;INTRAMUSCULAR","021866","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","TABLET, ORALLY DISINTEGRATING;ORAL","021729","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf#page=84"
"Abilify","Aripiprazole","TABLET;ORAL","021436","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77"
"Abilify","Aripiprazole","INJECTABLE;INTRAMUSCULAR","021866","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf#page=84"
"Abilify Maintena Kit","Aripiprazole","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","202971","OTSUKA PHARM CO LTD","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52"
"Abilify Mycite Kit","Aripiprazole","TABLET;ORAL","207202","OTSUKA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207202s002s004lbl.pdf#page=48"
"Abrilada","Adalimumab-Afzb","INJECTABLE;INJECTION","761118","PFIZER INC","11/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761118s000lbl.pdf#page=39"
"Absorica","Isotretinoin","CAPSULE;ORAL","021951","SUN PHARM INDS INC","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32"
"Abstral","Fentanyl Citrate","TABLET;SUBLINGUAL","022510","SENTYNL THERAPS INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29"
"Accutane","Isotretinoin","CAPSULE;ORAL","018662","HOFFMANN LA ROCHE","10/22/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf"
"Aciphex","Rabeprazole Sodium","TABLET, DELAYED RELEASE;ORAL","020973","EISAI INC","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020973s039lbl.pdf#page=34"
"Aciphex Sprinkle","Rabeprazole Sodium","CAPSULE, DELAYED RELEASE;ORAL","204736","AYTU","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204736s010lbl.pdf#page=21"
"Actemra","Tocilizumab","INJECTABLE; INJECTION","125276","GENENTECH","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125276s127,125472s040lbl.pdf#page=46"
"Actemra","Tocilizumab","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","125472","GENENTECH","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125276s127,125472s040lbl.pdf#page=46"
"Actemra","Tocilizumab","INJECTABLE; INJECTION","125276","GENENTECH","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125276s129,125472s042lbl.pdf#page=46"
"Actemra","Tocilizumab","INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","125472","GENENTECH","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125276s129,125472s042lbl.pdf#page=46"
"Actiq","Fentanyl Citrate","TROCHE/LOZENGE;TRANSMUCOSAL","020747","CEPHALON","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020747s049lbl.pdf#page=21"
"Actonel","Risedronate Sodium","TABLET;ORAL","020835","APIL","11/05/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38"
"Actonel","Risedronate Sodium","TABLET;ORAL","020835","APIL","11/05/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020835s048lbl.pdf#page=38"
"Actonel With Calcium (Copackaged)","Calcium Carbonate; Risedronate Sodium","TABLET, TABLET;ORAL","021823","WARNER CHILCOTT","04/08/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27"
"Actoplus MET","Metformin Hydrochloride; Pioglitazone Hydrochloride","TABLET;ORAL","021842","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41"
"Actoplus MET XR","Metformin Hydrochloride; Pioglitazone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022024","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41"
"Actos","Pioglitazone Hydrochloride","TABLET;ORAL","021073","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35"
"Adasuve","Loxapine","POWDER;INHALATION","022549","ALEXZA PHARMS","02/23/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022549s006lbl.pdf#page=26"
"Adderall 10","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 12.5","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 15","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 20","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 30","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 5","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall 7.5","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","TABLET;ORAL","011522","TEVA WOMENS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf"
"Adderall XR 10","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Adderall XR 15","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Adderall XR 20","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Adderall XR 25","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Adderall XR 30","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Adderall XR 5","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021303","TAKEDA PHARMS USA","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24"
"Addyi","Flibanserin","TABLET;ORAL","022526","SPROUT PHARMS","10/09/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23"
"Adempas","Riociguat","TABLET;ORAL","204819","BAYER HLTHCARE","02/10/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204819s006lbl.pdf#page=24"
"Adhansia XR","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","212038","PURDUE PHARMA LP","07/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212038s001lbl.pdf#page=24"
"Adlyxin","Lixisenatide","SOLUTION;SUBCUTANEOUS","208471","SANOFI-AVENTIS US","07/27/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208471Orig1s000lbl.pdf#page=31"
"Adzenys ER","Amphetamine","SUSPENSION, EXTENDED RELEASE;ORAL","204325","NEOS THERAPS INC","09/15/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204325s000lbl.pdf#page=26"
"Ambien","Zolpidem Tartrate","TABLET;ORAL","019908","SANOFI AVENTIS US","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019908s046lbl.pdf#page=23"
"Ambien CR","Zolpidem Tartrate","TABLET, EXTENDED RELEASE;ORAL","021774","SANOFI AVENTIS US","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021774s027lbl.pdf#page=26"
"Amjevita","Adalimumab-Atto","INJECTABLE;INJECTION","761024","AMGEN INC","06/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761024s004lbl.pdf#page=39"
"Ampyra","Dalfampridine","TABLET, EXTENDED RELEASE;ORAL","022250","ACORDA","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022250s015lbl.pdf#page=15"
"Ampyra","Dalfampridine","TABLET, EXTENDED RELEASE;ORAL","022250","ACORDA","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/22250s017lbl.pdf#page=14"
"Anafranil","Clomipramine Hydrochloride","CAPSULE;ORAL","019906","SPECGX LLC","05/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27"
"Anaprox","Naproxen Sodium","TABLET;ORAL","018164","ATNAHS PHARMA US","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017581s114,018164s064,020067s021lbl.pdf#page=22"
"Anaprox DS","Naproxen Sodium","TABLET;ORAL","018164","ATNAHS PHARMA US","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017581s114,018164s064,020067s021lbl.pdf#page=22"
"Androgel","Testosterone","GEL, METERED;TRANSDERMAL","022309","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25"
"Androgel","Testosterone","GEL, METERED;TRANSDERMAL","021015","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23"
"Androgel","Testosterone","GEL;TRANSDERMAL","021015","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23"
"Androgel","Testosterone","GEL;TRANSDERMAL","022309","ABBVIE","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25"
"Ansaid","Flurbiprofen","TABLET;ORAL","018766","PHARMACIA AND UPJOHN","05/09/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf"
"Apadaz","Acetaminophen; Benzhydrocodone Hydrochloride","TABLET;ORAL","208653","KVK TECH INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208653s005lbl.pdf#page=37"
"Aplenzin","Bupropion Hydrobromide","TABLET, EXTENDED RELEASE;ORAL","022108","VALEANT PHARMS NORTH","05/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022108s020lbl.pdf#page=28"
"Aplenzin","Bupropion Hydrobromide","TABLET, EXTENDED RELEASE;ORAL","022108","VALEANT PHARMS NORTH","05/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022108s014lbl.pdf#page=28"
"Aptensio XR","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","205831","RHODES PHARMS","06/14/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205831s005lbl.pdf#page=22"
"Aptiom","Eslicarbazepine Acetate","TABLET;ORAL","022416","SUNOVION PHARMS INC","03/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25"
"Aranesp","Darbepoetin Alfa","VIAL; INTRAVENOUS","103951","AMGEN","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25"
"Aranesp","Darbepoetin Alfa","VIAL; SUBCUTANEOUS","103951","AMGEN","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25"
"Arcapta Neohaler","Indacaterol Maleate","POWDER;INHALATION","022383","NOVARTIS","05/29/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf"
"Arikayce Kit","Amikacin Sulfate","SUSPENSION, LIPOSOMAL;INHALATION","207356","INSMED INC","03/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15"
"Aristada","Aripiprazole LAuroxil","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","207533","ALKERMES INC","11/30/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207533s004lbl.pdf#page=35"
"Arthrotec","Diclofenac Sodium; Misoprostol","TABLET, DELAYED RELEASE;ORAL","020607","GD SEARLE LLC","07/28/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm085919.pdf"
"Arthrotec","Diclofenac Sodium; Misoprostol","TABLET, DELAYED RELEASE;ORAL","020607","GD SEARLE LLC","07/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020406s033lbl.pdf#page=31"
"Arymo ER","Morphine Sulfate","TABLET, EXTENDED RELEASE;ORAL","208603","ZYLA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34"
"Arzerra","Ofatumumab","INJECTABLE; INJECTION","125326","NOVARTIS","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125326s070lbl.pdf#page=13"
"Astagraf XL","Tacrolimus","CAPSULE, EXTENDED RELEASE;ORAL","204096","ASTELLAS","06/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204096s007lbl.pdf#page=38"
"Atelvia","Risedronate Sodium","TABLET, DELAYED RELEASE;ORAL","022560","APIL","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24"
"Ativan","Lorazepam","TABLET;ORAL","017794","BAUSCH","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017794s044lbl.pdf#page=9"
"Aubagio","Teriflunomide","TABLET;ORAL","202992","SANOFI AVENTIS US","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202992s008lbl.pdf#page=24"
"Aubagio","Teriflunomide","TABLET;ORAL","202992","SANOFI AVENTIS US","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202992s006lbl.pdf#page=24"
"Austedo","Deutetrabenazine","TABLET;ORAL","208082","TEVA BRANDED PHARM","07/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208082s004lbl.pdf#page=25"
"Avandamet","Metformin Hydrochloride; Rosiglitazone Maleate","TABLET;ORAL","021410","SB PHARMCO","04/05/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38"
"Avandaryl","Glimepiride; Rosiglitazone Maleate","TABLET;ORAL","021700","SB PHARMCO","12/16/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021700s021lbl.pdf#page=39"
"Avandia","Rosiglitazone Maleate","TABLET;ORAL","021071","SB PHARMCO","02/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38"
"Aveed","Testosterone Undecanoate","INJECTABLE;INTRAMUSCULAR","022219","ENDO PHARMS INC","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23"
"Avelox","Moxifloxacin Hydrochloride","TABLET;ORAL","021085","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021085s065,021277s061lbl.pdf#page=33"
"Avelox","Moxifloxacin Hydrochloride","TABLET;ORAL","021085","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
"Avelox in Sodium Chloride 0.8% in Plastic Container","Moxifloxacin Hydrochloride","SOLUTION;INTRAVENOUS","021277","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021085s065,021277s061lbl.pdf#page=33"
"Avelox in Sodium Chloride 0.8% in Plastic Container","Moxifloxacin Hydrochloride","SOLUTION;INTRAVENOUS","021277","BAYER HLTHCARE","05/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33"
"Avinza","Morphine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","021260","KING PHARMS LLC","06/26/2015","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf"
"Avonex","Interferon Beta-1a","VIAL","103628","BIOGEN","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103628s5264lbl.pdf#page=21"
"Avsola","Infliximab-Axxq","INJECTABLE;INJECTION","761086","AMGEN INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48"
"Axiron","Testosterone","SOLUTION, METERED;TRANSDERMAL","022504","ELI LILLY AND CO","07/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15"
"Banzel","Rufinamide","TABLET;ORAL","021911","EISAI INC","11/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19"
"Banzel","Rufinamide","SUSPENSION;ORAL","201367","EISAI INC","11/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19"
"Bavencio","Avelumab","INJECTABLE;INJECTION","761049","EMD SERONO INC","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761049s009lbl.pdf#page=36"
"Bavencio","Avelumab","INJECTABLE;INTRAVENOUS","761078","EMD SERONO INC","05/09/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23"
"Baxdela","Delafloxacin Meglumine","TABLET;ORAL","208610","MELINTA","10/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s006,208611s005lbl.pdf#page=23"
"Baxdela","Delafloxacin Meglumine","POWDER;INTRAVENOUS","208611","MELINTA","10/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28"
"Baxdela","Delafloxacin Meglumine","POWDER;INTRAVENOUS","208611","MELINTA","10/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s006,208611s005lbl.pdf#page=23"
"Baxdela","Delafloxacin Meglumine","TABLET;ORAL","208610","MELINTA","10/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28"
"Belbuca","Buprenorphine Hydrochloride","FILM;BUCCAL","207932","BDSI","10/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207932s012lbl.pdf#page=37"
"Belbuca","Buprenorphine Hydrochloride","FILM;BUCCAL","207932","BDSI","10/16/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207932s002lbl.pdf#page=28"
"Belsomra","Suvorexant","TABLET;ORAL","204569","MERCK SHARP DOHME","03/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204569Orig1s007lbl.pdf#page=23"
"Belsomra","Suvorexant","TABLET;ORAL","204569","MERCK SHARP DOHME","03/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204569s006lbl.pdf#page23"
"Belsomra","Suvorexant","TABLET;ORAL","204569","MERCK SHARP DOHME","03/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204569s005lbl.pdf#page=22"
"Benlysta","Belimumab","INJECTABLE; INJECTION","125370","HUMAN GENOME SCIENCES INC.","01/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125370s067,761043s005lbl.pdf#page=32"
"Benlysta","Belimumab","INJECTABLE; INJECTION","125370","HUMAN GENOME SCIENCES INC.","01/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s068,761043s008lbl.pdf#page=33"
"Benlysta","Belimumab","INJECTABLE;INJECTION","761043","GLAXOSMITHKLINE LLC","01/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s068,761043s008lbl.pdf#page=33"
"Benlysta","Belimumab","INJECTABLE;INJECTION","761043","GLAXOSMITHKLINE LLC","01/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125370s067,761043s005lbl.pdf#page=32"
"Betaseron","Interferon Beta-1b","VIAL; SUBCUTANEOUS","103471","BAYER HEALTHCARE PHARMS","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103471s5193lbl.pdf#page=18"
"Bevyxxa","Betrixaban","CAPSULE;ORAL","208383","PORTOLA PHARMS INC","08/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20"
"Binosto","Alendronate Sodium","TABLET, EFFERVESCENT;ORAL","202344","ASCEND THERAPS US","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33"
"Blenrep","Belantamab Mafodotin-Blmf","INJECTABLE;INTRAVENOUS","761158","GLAXOSMITHKLINE","08/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761158s000lbl.pdf#page=21"
"Blincyto","Blinatumomab","INJECTABLE;INJECTION","125557","AMGEN","03/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125557s012lbl.pdf#page=33"
"Boniva","Ibandronate Sodium","INJECTABLE;INTRAVENOUS","021858","ROCHE","12/07/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18"
"Boniva","Ibandronate Sodium","TABLET;ORAL","021455","HOFFMANN LA ROCHE","12/07/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19"
"Bonsity","Teriparatide","SOLUTION;SUBCUTANEOUS","211939","ALVOGEN","10/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211939s000lbl.pdf#page=25"
"Botox","Onabotulinumtoxina","VIAL; SINGLE-USE","103000","ALLERGAN","07/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103000s5310lbl.pdf#page=47"
"Botox Cosmetic","Onabotulinumtoxina","VIAL; SINGLE-USE","103000","ALLERGAN","07/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103000s5310lbl.pdf#page=47"
"Braftovi","Encorafenib","CAPSULE;ORAL","210496","ARRAY BIOPHARMA INC","04/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210496s003lbl.pdf#page=18"
"Brilinta","Ticagrelor","TABLET;ORAL","022433","ASTRAZENECA PHARMS","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022433s028lbl.pdf#page=29"
"Brilinta","Ticagrelor","TABLET;ORAL","022433","ASTRAZENECA PHARMS","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022433s023lbl.pdf#page=27"
"Brilinta","Ticagrelor","TABLET;ORAL","022433","ASTRAZENECA PHARMS","05/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022433s025lbl.pdf#page=26"
"Brisdelle","Paroxetine Mesylate","CAPSULE;ORAL","204516","SEBELA IRELAND LTD","04/28/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204516s005lbl.pdf#page=22"
"Briviact","Brivaracetam","TABLET;ORAL","205836","UCB INC","05/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205836s005,205837s004,205838s003lbl.pdf#page=17"
"Briviact","Brivaracetam","SOLUTION;INTRAVENOUS","205837","UCB INC","05/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205836s005,205837s004,205838s003lbl.pdf#page=17"
"Briviact","Brivaracetam","SOLUTION;ORAL","205838","UCB INC","05/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205836s005,205837s004,205838s003lbl.pdf#page=17"
"Brovana","Arformoterol Tartrate","SOLUTION;INHALATION","021912","SUNOVION","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22"
"Bunavail","Buprenorphine Hydrochloride; Naloxone Hydrochloride","FILM;BUCCAL","205637","BDSI","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205637s020lbl.pdf#page=31"
"Butrans","Buprenorphine","FILM, EXTENDED RELEASE;TRANSDERMAL","021306","PURDUE PHARMA LP","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021306s035lbl.pdf#page=42"
"Bydureon","Exenatide Synthetic","FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","022200","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022200s026lbl.pdf#page=31"
"Bydureon Bcise","Exenatide","SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","209210","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209210s002s003s004s005s006s007s008lbl.pdf#page=32"
"Bydureon Bcise","Exenatide","SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","209210","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209210s011lbl.pdf#page=33"
"Bydureon Pen","Exenatide Synthetic","FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS","022200","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022200s026lbl.pdf#page=31"
"Byetta","Exenatide Synthetic","INJECTABLE;SUBCUTANEOUS","021773","ASTRAZENECA AB","02/28/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf"
"Byetta","Exenatide Synthetic","INJECTABLE;SUBCUTANEOUS","021773","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021773s043lbl.pdf#page=35"
"Byetta","Exenatide Synthetic","INJECTABLE;SUBCUTANEOUS","021773","ASTRAZENECA AB","02/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021773s041lbl.pdf#page=32"
"Byetta","Exenatide Synthetic","INJECTABLE; SUBCUTANEOUS","021919","AMYLIN","10/30/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf"
"Cambia","Diclofenac Potassium","FOR SOLUTION;ORAL","022165","ASSERTIO","03/20/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM169077.pdf"
"Cambia","Diclofenac Potassium","FOR SOLUTION;ORAL","022165","ASSERTIO","03/20/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022165s012lbl.pdf#page=19"
"Campath","Alemtuzumab","VIAL; INTRAVENOUS","103948","GENZYME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf#page=28"
"Campath","Alemtuzumab","VIAL; INTRAVENOUS","103948","GENZYME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5173lbl.pdf#page=29"
"Caprelsa","Vandetanib","TABLET;ORAL","022405","GENZYME CORP","06/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022405s017lbl.pdf#page=20"
"Carbatrol","Carbamazepine","CAPSULE, EXTENDED RELEASE;ORAL","020712","TAKEDA PHARMS USA","08/26/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035mg.pdf"
"Cassipa","Buprenorphine Hydrochloride; Naloxone Hydrochloride","FILM;SUBLINGUAL","208042","TEVA PHARMS USA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208042s001lbl.pdf#page=27"
"Cataflam","Diclofenac Potassium","TABLET;ORAL","020142","NOVARTIS","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM135935.pdf"
"Celebrex","Celecoxib","CAPSULE;ORAL","020998","GD SEARLE","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020998s054lbl.pdf#page=21"
"Celebrex","Celecoxib","CAPSULE;ORAL","021156","GD SEARLE LLC","02/04/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf"
"Celexa","Citalopram Hydrobromide","SOLUTION;ORAL","021046","FOREST LABS","12/03/2012","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088568.pdf"
"Celexa","Citalopram Hydrobromide","TABLET;ORAL","020822","ALLERGAN","01/11/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020822s047lbl.pdf#page=33"
"Cellcept","Mycophenolate Mofetil","TABLET;ORAL","050723","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050722s035,050723s035,050758s033,050759s041lbl.pdf#page=39"
"Cellcept","Mycophenolate Mofetil Hydrochloride","INJECTABLE;INJECTION","050758","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050722s040,050723s041,050758s037,050759s045lbl.pdf#page=38"
"Cellcept","Mycophenolate Mofetil","CAPSULE;ORAL","050722","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050722s035,050723s035,050758s033,050759s041lbl.pdf#page=39"
"Cellcept","Mycophenolate Mofetil","SUSPENSION;ORAL","050759","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050722s035,050723s035,050758s033,050759s041lbl.pdf#page=39"
"Cellcept","Mycophenolate Mofetil","SUSPENSION;ORAL","050759","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050722s040,050723s041,050758s037,050759s045lbl.pdf#page=38"
"Cellcept","Mycophenolate Mofetil Hydrochloride","INJECTABLE;INJECTION","050758","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050722s035,050723s035,050758s033,050759s041lbl.pdf#page=39"
"Cellcept","Mycophenolate Mofetil","TABLET;ORAL","050723","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050722s040,050723s041,050758s037,050759s045lbl.pdf#page=38"
"Cellcept","Mycophenolate Mofetil","CAPSULE;ORAL","050722","ROCHE PALO","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050722s040,050723s041,050758s037,050759s045lbl.pdf#page=38"
"Celontin","Methsuximide","CAPSULE;ORAL","010596","PARKE DAVIS","06/15/2011","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf"
"Cerdelga","Eliglustat Tartrate","CAPSULE;ORAL","205494","GENZYME CORP","08/29/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494Orig1s000lbl.pdf"
"Cerdelga","Eliglustat Tartrate","CAPSULE;ORAL","205494","GENZYME CORP","08/29/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19"
"Chantix","Varenicline Tartrate","TABLET;ORAL","021928","PF PRISM CV","02/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22"
"Children's Cetirizine Hydrochloride Allergy","Cetirizine Hydrochloride","SYRUP;ORAL","212266","QUAGEN","05/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212266s000lbl.pdf#page=14"
"Chlordiazepoxide and Amitriptyline Hydrochloride","Amitriptyline Hydrochloride; Chlordiazepoxide","TABLET;ORAL","071297","MYLAN PHARMS INC","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf"
"Cimzia","Certolizumab Pegol","INJECTABLE; INJECTION","125160","UCB INC","09/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s237lbl.pdf#page=40"
"Cimzia","Certolizumab Pegol","INJECTABLE; INJECTION","125160","UCB INC","09/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125160s283lbl.pdf#page=37"
"Cimzia","Certolizumab Pegol","INJECTABLE; INJECTION","125160","UCB INC","09/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s293lbl.pdf#page=41"
"Cimzia","Certolizumab Pegol","INJECTABLE; INJECTION","125160","UCB INC","09/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s289lbl.pdf#page=39"
"Cipro","Ciprofloxacin","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","05/08/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246794.pdf"
"Cipro","Ciprofloxacin","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019847s059lbl.pdf#page=32"
"Cipro","Ciprofloxacin","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019847s061lbl.pdf#page=33"
"Cipro","Ciprofloxacin","FOR SUSPENSION;ORAL","020780","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019537s091,020780s048lbl.pdf#page=39"
"Cipro","Ciprofloxacin Hydrochloride","TABLET;ORAL","019537","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019537s091,020780s048lbl.pdf#page=39"
"Cipro","Ciprofloxacin","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019847s060lbl.pdf#page=32"
"Cipro","Ciprofloxacin","INJECTABLE;INJECTION","019847","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019847s062lbl.pdf#page=33"
"Cipro","Ciprofloxacin Hydrochloride","TABLET;ORAL","019537","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019537s090,020780s047lbl.pdf#page=39"
"Cipro","Ciprofloxacin","FOR SUSPENSION;ORAL","020780","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019537s090,020780s047lbl.pdf#page=39"
"Cipro in Dextrose 5% in Plastic Container","Ciprofloxacin","INJECTABLE;INJECTION","019857","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019857s070lbl.pdf#page=33"
"Cipro in Dextrose 5% in Plastic Container","Ciprofloxacin","INJECTABLE;INJECTION","019857","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019857s066lbl.pdf#page=33"
"Cipro in Dextrose 5% in Plastic Container","Ciprofloxacin","INJECTABLE;INJECTION","019857","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019857s072lbl.pdf#page=33"
"Cipro XR","Ciprofloxacin; Ciprofloxacin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021473","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021473s041lbl.pdf#page=29"
"Cipro XR","Ciprofloxacin; Ciprofloxacin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021473","BAYER HLTHCARE","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021473s042lbl.pdf#page=30"
"Clenpiq","Citric Acid; Magnesium Oxide; Sodium Picosulfate","SOLUTION;ORAL","209589","FERRING PHARMS INC","10/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209589s006lbledt.pdf#page=14"
"Clinoril","Sulindac","TABLET;ORAL","017911","MERCK","12/23/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf"
"Codeine Sulfate","Codeine Sulfate","TABLET;ORAL","022402","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022402s012lbl.pdf#page=29"
"Codeine Sulfate","Codeine Sulfate","SOLUTION;ORAL","202245","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf#page=27"
"Codeine Sulfate","Codeine Sulfate","SOLUTION;ORAL","202245","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202245s005lbl.pdf#page=26"
"Codeine Sulfate","Codeine Sulfate","SOLUTION;ORAL","202245","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202245s008lbl.pdf#page=28"
"Colcrys","Colchicine","TABLET; ORAL","022353","AR HOLDING CO INC","10/16/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM176363.pdf"
"Colcrys","Colchicine","TABLET;ORAL","022352","TAKEDA PHARMS USA","05/14/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022352s022lbl.pdf#page=24"
"Colcrys","Colchicine","TABLET;ORAL","022352","TAKEDA PHARMS USA","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25"
"Combunox","Ibuprofen; Oxycodone Hydrochloride","TABLET;ORAL","021378","FOREST LABS","09/02/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088574.pdf"
"Concerta","Methylphenidate Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021121","JANSSEN PHARMS","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021121s038lbl.pdf#page=30"
"Contrave","Bupropion Hydrochloride; Naltrexone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200063","NALPROPION","08/04/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/200063s013lbl.pdf#page=39"
"Contrave","Bupropion Hydrochloride; Naltrexone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200063","NALPROPION","08/04/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200063s015lbl.pdf#page=40"
"Conzip","Tramadol Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","022370","CIPHER PHARMS INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022370s018lbl.pdf#page=34"
"Copegus","Ribavirin","TABLET;ORAL","021511","ROCHE","08/11/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27"
"Cordarone","Amiodarone Hydrochloride","TABLET;ORAL","018972","WYETH PHARMS","10/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018972s053lbl.pdf#page=22"
"Cordarone","Amiodarone Hydrochloride","TABLET;ORAL","018972","WYETH PHARMS","10/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13"
"Corlanor","Ivabradine Hydrochloride","TABLET;ORAL","206143","AMGEN INC","05/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206143s007lbl.pdf#page=24"
"Corlanor","Ivabradine","SOLUTION;ORAL","209964","AMGEN INC","04/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209964lbl.pdf#page=24"
"Corlanor","Ivabradine Hydrochloride","TABLET;ORAL","206143","AMGEN INC","05/13/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206143Orig1s002lbl.pdf#page=20"
"Cosentyx","Secukinumab","INJECTABLE;INJECTION","125504","NOVARTIS PHARMS CORP","06/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125504s031lbl.pdf#page=20"
"Cosentyx","Secukinumab","INJECTABLE;INJECTION","125504","NOVARTIS PHARMS CORP","06/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125504s035lbl.pdf#page=22"
"Cotempla XR-Odt","Methylphenidate","TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL","205489","NEOS THERAPS INC","06/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205489s000lbl.pdf#page=21"
"Coumadin","Warfarin Sodium","INJECTABLE;INJECTION","009218","BRISTOL MYERS SQUIBB","08/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30"
"Coumadin","Warfarin Sodium","TABLET;ORAL","009218","BRISTOL MYERS SQUIBB","08/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30"
"Creon","Pancrelipase (Amylase;Lipase;Protease)","CAPSULE, DELAYED RELEASE;ORAL","020725","ABBVIE","03/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020725s026lbl.pdf#page=16"
"Cyltezo","Adalimumab-Adbm","INJECTABLE;INJECTION","761058","BOEHRINGER INGELHEIM","09/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761058s003lbl.pdf#page=30"
"Cymbalta","Duloxetine Hydrochloride","CAPSULE, DELAYED REL PELLETS;ORAL","021427","LILLY","04/20/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021427s049lbl.pdf#page=32"
"Cymbalta","Duloxetine Hydrochloride","CAPSULE, DELAYED REL PELLETS;ORAL","021427","LILLY","04/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021427s052lbl.pdf#page=38"
"Cymbalta","Duloxetine Hydrochloride","CAPSULE, DELAYED REL PELLETS;ORAL","021427","LILLY","04/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021427s051lbl.pdf#page=33"
"Daliresp","Roflumilast","TABLET;ORAL","022522","ASTRAZENECA PHARMS","01/23/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17"
"Dalmane","Flurazepam Hydrochloride","CAPSULE;ORAL","016721","VALEANT PHARM INTL","03/27/2009","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf"
"Darvocet-N 100","Acetaminophen; Propoxyphene Napsylate","TABLET;ORAL","017122","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"
"Darvocet-N 50","Acetaminophen; Propoxyphene Napsylate","TABLET;ORAL","017122","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf"
"Darvon","Propoxyphene Hydrochloride","CAPSULE;ORAL","010997","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"
"Darvon-N","Propoxyphene Napsylate","TABLET;ORAL","016862","XANODYNE PHARM","09/25/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf"
"Daurismo","Glasdegib Maleate","TABLET;ORAL","210656","PFIZER","03/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210656s002s004lbl.pdf#page=20"
"Daypro","Oxaprozin","TABLET;ORAL","018841","PFIZER","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018841s030lbl.pdf#page=24"
"Daypro","Oxaprozin","TABLET;ORAL","018841","PFIZER","05/03/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501638.pdf"
"Daypro Alta","Oxaprozin Potassium","TABLET;ORAL","020776","PFIZER","05/03/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088580.pdf"
"Daypro Alta","Oxaprozin Potassium","TABLET;ORAL","020776","PFIZER","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020776s008lbl.pdf#page=21"
"Daytrana","Methylphenidate","FILM, EXTENDED RELEASE;TRANSDERMAL","021514","NOVEN PHARMS INC","10/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021514s028lbl.pdf#page=23"
"Dayvigo","Lemborexant","TABLET;ORAL","212028","EISAI INC","08/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf#page=21"
"Demerol","Meperidine Hydrochloride","SYRUP;ORAL","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005010s058lbl.pdf#page=31"
"Demerol","Meperidine Hydrochloride","TABLET;ORAL","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005010s058lbl.pdf#page=31"
"Demerol","Meperidine Hydrochloride","SYRUP;ORAL","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005010s056s057lbl.pdf#page=30"
"Demerol","Meperidine Hydrochloride","INJECTABLE;INJECTION","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005010s058lbl.pdf#page=31"
"Demerol","Meperidine Hydrochloride","TABLET;ORAL","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005010s056s057lbl.pdf#page=30"
"Demerol","Meperidine Hydrochloride","INJECTABLE;INJECTION","005010","US PHARM HOLDINGS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005010s056s057lbl.pdf#page=30"
"Depakene","Valproic Acid","CAPSULE;ORAL","018081","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41"
"Depakene","Valproic Acid","SYRUP;ORAL","018082","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38"
"Depakote","Divalproex Sodium","CAPSULE, DELAYED REL PELLETS;ORAL","019680","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019680s050lbl.pdf#page=42"
"Depakote","Divalproex Sodium","CAPSULE, DELAYED REL PELLETS;ORAL","019680","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019680s049lbl.pdf#page=42"
"Depakote","Divalproex Sodium","TABLET, DELAYED RELEASE;ORAL","018723","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018723s062lbl.pdf#page=48"
"Depakote","Divalproex Sodium","TABLET, DELAYED RELEASE;ORAL","018723","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018723s063lbl.pdf#page=48"
"Depakote ER","Divalproex Sodium","TABLET, EXTENDED RELEASE;ORAL","021168","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021168s040lbl.pdf#page=47"
"Depakote ER","Divalproex Sodium","TABLET, EXTENDED RELEASE;ORAL","021168","ABBVIE","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021168s038lbl.pdf#page=44"
"Descovy","Emtricitabine; Tenofovir Alafenamide Fumarate","TABLET;ORAL","208215","GILEAD SCIENCES INC","12/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s011lbl.pdf#page=37"
"Desoxyn","Methamphetamine Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","005378","RECORDATI RARE","04/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005378s035lbl.pdf#page=12"
"Desoxyn","Methamphetamine Hydrochloride","TABLET;ORAL","005378","RECORDATI RARE","04/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005378s035lbl.pdf#page=12"
"Desvenlafaxine","Desvenlafaxine","TABLET, EXTENDED RELEASE;ORAL","204150","ALEMBIC PHARMS LTD","10/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204150s007lbl.pdf#page=30"
"Desvenlafaxine","Desvenlafaxine","TABLET, EXTENDED RELEASE;ORAL","204150","ALEMBIC PHARMS LTD","10/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204150s010lbl.pdf#page=31"
"Desvenlafaxine","Desvenlafaxine Fumarate","TABLET, EXTENDED RELEASE;ORAL","205208","TEVA PHARMS USA","07/18/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM372058.pdf"
"Desvenlafaxine","Desvenlafaxine Fumarate","TABLET, EXTENDED RELEASE;ORAL","205583","SUN PHARMA GLOBAL","12/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205583s010lbl.pdf#page=30"
"Desyrel","Trazodone Hydrochloride","TABLET;ORAL","018207","PRAGMA","10/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13"
"Desyrel","Trazodone Hydrochloride","TABLET;ORAL","018207","PRAGMA","10/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14"
"Dexedrine","Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","017078","IMPAX LABS INC","01/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017078s050lbl.pdf#page=9"
"Dexedrine","Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","017078","IMPAX LABS INC","01/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017078s052lbl.pdf#page=11"
"Dexilant","Dexlansoprazole","CAPSULE, DELAYED RELEASE;ORAL","022287","TAKEDA PHARMS USA","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022287s029s030lbl.pdf#page=24"
"Dextroamphetamine Sulfate","Dextroamphetamine Sulfate","SOLUTION;ORAL","040776","OUTLOOK PHARMS","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088583.pdf"
"Diacomit","Stiripentol","FOR SUSPENSION;ORAL","207223","BIOCODEX SA","08/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
"Diacomit","Stiripentol","CAPSULE;ORAL","206709","BIOCODEX SA","08/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17"
"Dilantin","Phenytoin Sodium","CAPSULE;ORAL","084349","UPJOHN","08/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/084349s085lbl.pdf#page=19"
"Dilantin","Phenytoin","TABLET, CHEWABLE;ORAL","084427","UPJOHN","12/03/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17"
"Dilantin-125","Phenytoin","SUSPENSION;ORAL","008762","UPJOHN","07/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/008762s060s061lbl.pdf#page=18"
"Dilantin-30","Phenytoin","SUSPENSION;ORAL","008762","UPJOHN","07/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/008762s060s061lbl.pdf#page=18"
"Dilaudid","Hydromorphone Hydrochloride","SOLUTION;ORAL","019891","RHODES PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019891s028,019892s035lbl.pdf#page=28"
"Dilaudid","Hydromorphone Hydrochloride","TABLET;ORAL","019892","RHODES PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019891s028,019892s035lbl.pdf#page=28"
"Dolophine Hydrochloride","Methadone Hydrochloride","SYRUP;ORAL","006134","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/006134s049lbl.pdf#page=34"
"Dolophine Hydrochloride","Methadone Hydrochloride","TABLET;ORAL","006134","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/006134s049lbl.pdf#page=34"
"Doral","Quazepam","TABLET;ORAL","018708","GALT PHARMS","02/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018708s025lbl.pdf#page=12"
"Doral","Quazepam","TABLET;ORAL","018708","GALT PHARMS","02/06/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018708s023lbl.pdf#page=12"
"Dotarem","Gadoterate Meglumine","SOLUTION;INTRAVENOUS","204781","GUERBET","07/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17"
"Dotarem","Gadoterate Meglumine","SOLUTION;INTRAVENOUS","204781","GUERBET","07/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204781s009lbl.pdf#page=29"
"Drizalma Sprinkle","Duloxetine Hydrochloride","CAPSULE, DELAYED RELEASE;ORAL","212516","SUN PHARMA GLOBAL","06/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212516s001lbl.pdf#page=49"
"Drizalma Sprinkle","Duloxetine Hydrochloride","CAPSULE, DELAYED RELEASE;ORAL","212516","SUN PHARMA GLOBAL","06/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212516s000lbl.pdf#page=42"
"Droxia","Hydroxyurea","CAPSULE;ORAL","016295","BRISTOL MYERS SQUIBB","12/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016295s049s050lbl.pdf#page=15"
"Droxia","Hydroxyurea","CAPSULE;ORAL","016295","BRISTOL MYERS SQUIBB","12/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016295s051lbl.pdf#page=27"
"Duetact","Glimepiride; Pioglitazone Hydrochloride","TABLET;ORAL","021925","TAKEDA PHARMS USA","12/21/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39"
"Duexis","Famotidine; Ibuprofen","TABLET;ORAL","022519","HORIZON","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022519s011lbl.pdf#page=22"
"Duexis","Famotidine; Ibuprofen","TABLET;ORAL","022519","HORIZON","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022519s012lbl.pdf#page=23"
"Duragesic-100","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duragesic-12","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duragesic-25","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duragesic-37","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duragesic-50","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duragesic-75","Fentanyl","FILM, EXTENDED RELEASE;TRANSDERMAL","019813","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019813s079lbl.pdf#page=50"
"Duzallo","Allopurinol; Lesinurad","TABLET;ORAL","209203","IRONWOOD PHARMS INC","08/18/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27"
"Dyanavel XR","Amphetamine","SUSPENSION, EXTENDED RELEASE;ORAL","208147","TRIS PHARMA INC","02/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/ 208147s005lbl.pdf#page=17"
"Dyanavel XR","Amphetamine","SUSPENSION, EXTENDED RELEASE;ORAL","208147","TRIS PHARMA INC","02/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208147s003lbl.pdf#page=15"
"Dysport","Abobotulinumtoxina","INJECTABLE; INJECTION","125274","IPSEN BIOPHARM LTD","07/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125274s115lbl.pdf#page=31"
"EC-Naprosyn","Naproxen","TABLET, DELAYED RELEASE;ORAL","020067","ATNAHS PHARMA US","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017581s114,018164s064,020067s021lbl.pdf#page=22"
"Edluar","Zolpidem Tartrate","TABLET;SUBLINGUAL","021997","MYLAN SPECIALITY LP","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23"
"Effexor","Venlafaxine Hydrochloride","TABLET;ORAL","020151","WYETH PHARMS INC","12/12/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34"
"Effexor XR","Venlafaxine Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","020699","UPJOHN","12/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020699s110s111lbl.pdf#page=36"
"Effient","Prasugrel Hydrochloride","TABLET;ORAL","022307","ELI LILLY AND CO","03/28/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM238428.pdf"
"Effient","Prasugrel Hydrochloride","TABLET;ORAL","022307","ELI LILLY AND CO","03/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022307s014lbl.pdf#page=19"
"Effient","Prasugrel Hydrochloride","TABLET;ORAL","022307","ELI LILLY AND CO","03/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022307s016lbl.pdf#page=20"
"Elepsia XR","Levetiracetam","TABLET, EXTENDED RELEASE;ORAL","204417","SPARC","12/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204417s000lbl.pdf#page=27"
"Elidel","Pimecrolimus","CREAM;TOPICAL","021302","BAUSCH","06/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf"
"Eliquis","Apixaban","TABLET;ORAL","202155","BRISTOL MYERS SQUIBB","11/26/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202155s020lbl.pdf#page=40"
"Eliquis","Apixaban","TABLET;ORAL","202155","BRISTOL MYERS SQUIBB","11/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202155s021lbl.pdf#page=41"
"Eliquis","Apixaban","TABLET;ORAL","202155","BRISTOL MYERS SQUIBB","11/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202155s024lbl.pdf#page=37"
"Elyxyb","Celecoxib","SOLUTION;ORAL","212157","DR REDDYS","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212157s000lbl.pdf#page=24"
"Embeda","Morphine Sulfate; Naltrexone Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","022321","ALPHARMA PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022321s028s029lbl.pdf#page=28"
"Embeda","Morphine Sulfate; Naltrexone Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","022321","ALPHARMA PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30"
"Emsam","Selegiline","FILM, EXTENDED RELEASE;TRANSDERMAL","021336","SOMERSET","07/14/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34"
"Emsam","Selegiline","SYSTEM; TRANSDERMAL","021708","SOMERSET","02/27/2006","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088589.pdf"
"Enbrel","Etanercept","SYRINGE","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/ 103795s5569lbl.pdf#page=34"
"Enbrel","Etanercept","VIAL; SUBCUTANEOUS","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103795s5574s5577lbl.pdf#page=35"
"Enbrel","Etanercept","SYRINGE","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103795s5563s5564lbl.pdf#page=34"
"Enbrel","Etanercept","VIAL; SUBCUTANEOUS","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103795s5563s5564lbl.pdf#page=34"
"Enbrel","Etanercept","VIAL; SUBCUTANEOUS","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/ 103795s5569lbl.pdf#page=34"
"Enbrel","Etanercept","SYRINGE","103795","IMMUNEX","03/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103795s5574s5577lbl.pdf#page=35"
"Entyvio","Vedolizumab","INJECTABLE;INJECTION","125476","TAKEDA PHARMS USA","03/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125476s024lbl.pdf#page20"
"Entyvio","Vedolizumab","INJECTABLE;INJECTION","125476","TAKEDA PHARMS USA","03/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125476s022lbl.pdf#page=20"
"Entyvio","Vedolizumab","INJECTABLE;INJECTION","125476","TAKEDA PHARMS USA","03/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125476s025s030lbl.pdf#page=20"
"Envarsus XR","Tacrolimus","TABLET, EXTENDED RELEASE;ORAL","206406","VELOXIS PHARMS INC","12/19/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206406s007lbl.pdf#page=29"
"Eovist","Gadoxetate Disodium","SOLUTION;INTRAVENOUS","022090","BAYER HLTHCARE","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022090s015,201277s015lbl.pdf#page=51"
"Epidiolex","Cannabidiol","SOLUTION;ORAL","210365","GW RES LTD","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210365s005s006s007lbl.pdf#page=29"
"Epogen/Procrit","Epoetin Alfa","VIAL; MULTIDOSE","103234","AMGEN","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27"
"Epogen/Procrit","Epoetin Alfa","VIAL; SINGLE-USE","103234","AMGEN","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27"
"Epzicom","Abacavir Sulfate; LAmivudine","TABLET;ORAL","021652","VIIV HLTHCARE","05/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021652s023lbl.pdf#page=28"
"Equetro","Carbamazepine","CAPSULE, EXTENDED RELEASE;ORAL","021710","VALIDUS PHARMS","09/23/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021710s11s012lbl.pdf#page=22"
"Erelzi","Etanercept-Szzs","INJECTABLE; INJECTION","761042","SANDOZ","06/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761042s012lbl.pdf#page=39"
"Erivedge","Vismodegib","CAPSULE;ORAL","203388","GENENTECH","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203388s014lbl.pdf#page=13"
"Erivedge","Vismodegib","CAPSULE;ORAL","203388","GENENTECH","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203388s011lbl.pdf#page=12"
"Erivedge","Vismodegib","CAPSULE;ORAL","203388","GENENTECH","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203388s012lbl.pdf#page=13"
"Erivedge","Vismodegib","CAPSULE;ORAL","203388","GENENTECH","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203388s016lbl.pdf#page=14"
"Esomeprazole Strontium","Esomeprazole Strontium","CAPSULE, DELAYED RELEASE;ORAL","202342","BELCHER","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202342s005lbl.pdf#page=29"
"Estazolam","Estazolam","TABLET;ORAL","074921","MAYNE PHARMA","02/06/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf"
"Eticovo","Etanercept-Ykro","INJECTABLE;INJECTION","761066","SAMSUNG BIOEPIS CO LTD","04/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31"
"Evekeo ODT","Amphetamine Sulfate","TABLET, ORALLY DISINTEGRATING;ORAL","209905","ARBOR PHARMS LLC","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209905s000lbl.pdf#page=15"
"Evenity","Romosozumab-Aqqg","INJECTABLE;INJECTION","761062","AMGEN INC","12/20/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19"
"Evista","Raloxifene Hydrochloride","TABLET;ORAL","020815","LILLY","06/27/2018","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf"
"Evista","Raloxifene Hydrochloride","TABLET; ORAL","022042","LILLY","09/13/2007","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf"
"Exalgo","Hydromorphone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021217","SPECGX LLC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31"
"Exjade","Deferasirox","TABLET, FOR SUSPENSION;ORAL","021882","NOVARTIS","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28"
"Extavia","Interferon Beta-1b","INJECTABLE; SUBCUTANEOUS","125290","NOVARTIS PHARMS","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125290s067lbl.pdf#page=16"
"Extraneal","Icodextrin","SOLUTION;INTRAPERITONEAL","021321","BAXTER HLTHCARE","12/04/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM135933.pdf"
"Factive","Gemifloxacin Mesylate","TABLET;ORAL","021158","LG CHEM LTD","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30"
"Farxiga","Dapagliflozin","TABLET;ORAL","202293","ASTRAZENECA AB","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202293s018lbl.pdf#page=38"
"Farxiga","Dapagliflozin","TABLET;ORAL","202293","ASTRAZENECA AB","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202293s022lbl.pdf#page=38"
"Farxiga","Dapagliflozin","TABLET;ORAL","202293","ASTRAZENECA AB","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202293s020lbl.pdf#page=47"
"Farxiga","Dapagliflozin","TABLET;ORAL","202293","ASTRAZENECA AB","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202293s021lbl.pdf#page=38"
"Farydak","Panobinostat LActate","CAPSULE;ORAL","205353","SECURA","06/06/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf"
"Felbatol","Felbamate","TABLET;ORAL","020189","MYLAN SPECIALITY LP","08/31/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf"
"Felbatol","Felbamate","SUSPENSION;ORAL","020189","MYLAN SPECIALITY LP","08/31/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf"
"Feldene","Piroxicam","CAPSULE;ORAL","018147","PFIZER","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018147s044lbl.pdf#page=16"
"Feldene","Piroxicam","CAPSULE;ORAL","018147","PFIZER","05/03/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018147s048lbl.pdf#page=16"
"Fensolvi Kit","Leuprolide Acetate","POWDER;SUBCUTANEOUS","213150","TOLMAR","05/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213150s000lbl.pdf#page=15"
"Fentanyl Citrate","Fentanyl Citrate","TROCHE/LOZENGE;TRANSMUCOSAL","078907","SPECGX LLC","09/07/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf"
"Fentanyl Citrate","Fentanyl Citrate","TROCHE/LOZENGE;TRANSMUCOSAL","077312","PAR PHARM","09/07/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf"
"Fentora","Fentanyl Citrate","TABLET;BUCCAL, SUBLINGUAL","021947","CEPHALON","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021947s029lbl.pdf#page=20"
"Ferriprox","Deferiprone","TABLET;ORAL","021825","CHIESI","02/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021825s004lbl.pdf#page=11"
"Ferriprox","Deferiprone","SOLUTION;ORAL","208030","CHIESI","02/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208030s002lbl.pdf#page=11"
"Ferriprox","Deferiprone","TABLET;ORAL","212269","CHIESI","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212266s000lbl.pdf#page=14"
"Ferriprox","Deferiprone","SOLUTION;ORAL","208030","CHIESI","02/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208030s004lbl.pdf#page=11"
"Ferriprox","Deferiprone","TABLET;ORAL","021825","CHIESI","02/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/ 021825s007lbl.pdf#page=21"
"Fetzima","Levomilnacipran Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","204168","ALLERGAN","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204168s006lbl.pdf#page=28"
"Fintepla","Fenfluramine Hydrochloride","SOLUTION;ORAL","212102","ZOGENIX INC","06/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212102s000lbl.pdf#page=23"
"Fioricet W/ Codeine","Acetaminophen; Butalbital; Caffeine; Codeine Phosphate","CAPSULE;ORAL","020232","ACTAVIS LABS UT INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020232s044lbl.pdf#page=41"
"Fiorinal W/Codeine","Aspirin; Butalbital; Caffeine; Codeine Phosphate","CAPSULE;ORAL","019429","ALLERGAN","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019429s043lbl.pdf#page=39"
"Firdapse","Amifampridine Phosphate","TABLET;ORAL","208078","CATALYST PHARMS","11/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208078s000lbl.pdf#page=11"
"Flector","Diclofenac Epolamine","SYSTEM;TOPICAL","021234","INST BIOCHEM","03/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021234s015lbl.pdf#page=21"
"Flector","Diclofenac Epolamine","SYSTEM;TOPICAL","021234","INST BIOCHEM","03/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021234s016s017lbl.pdf#page=22"
"Flowtuss","Guaifenesin; Hydrocodone Bitartrate","SOLUTION;ORAL","022424","BKK PHARMS","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022424s002lbl.pdf#page=26"
"Floxin","Ofloxacin","TABLET;ORAL","019735","JANSSEN PHARMS","02/25/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf"
"Fluoxetine Hydrochloride","Fluoxetine Hydrochloride","TABLET;ORAL","202133","ALVOGEN","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202133s004s005lbl.pdf#page=40"
"Focalin","Dexmethylphenidate Hydrochloride","TABLET;ORAL","021278","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021278s011s019lbl.pdf#page=15"
"Focalin","Dexmethylphenidate Hydrochloride","TABLET;ORAL","021278","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021278s026lbl.pdf#page=14"
"Focalin","Dexmethylphenidate Hydrochloride","TABLET;ORAL","021278","NOVARTIS","11/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021278s023lbl.pdf#page=14"
"Focalin XR","Dexmethylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021802","NOVARTIS","11/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021802s033lbl.pdf#page=17"
"Focalin XR","Dexmethylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021802","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021802s036lbl.pdf#page=18"
"Focalin XR","Dexmethylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021802","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021802s019s029lbl.pdf#page=19"
"Foradil","Formoterol Fumarate","POWDER;INHALATION","020831","NOVARTIS","03/02/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf"
"Foradil Certihaler","Formoterol Fumarate","POWDER;INHALATION","021592","NOVARTIS","06/02/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088603.pdf"
"Forfivo XL","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022497","ALVOGEN","12/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022497s004lbl.pdf#page=32"
"Forfivo XL","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022497","ALVOGEN","12/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33"
"Forteo","Teriparatide","SOLUTION;SUBCUTANEOUS","021318","LILLY","04/06/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088604.pdf"
"Fortesta","Testosterone","GEL, METERED;TRANSDERMAL","021463","ENDO PHARMS","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21"
"Fosamax","Alendronate Sodium","TABLET;ORAL","020560","MERCK AND CO INC","08/16/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241519.pdf"
"Fosamax","Alendronate Sodium","TABLET;ORAL","020560","MERCK AND CO INC","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
"Fosamax","Alendronate Sodium","SOLUTION;ORAL","021575","MERCK","11/30/2015","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241519.pdf"
"Fosamax","Alendronate Sodium","SOLUTION;ORAL","021575","MERCK","11/30/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24"
"Fosamax Plus D","Alendronate Sodium; Cholecalciferol","TABLET;ORAL","021762","MERCK","08/16/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf"
"Fosamax Plus D","Alendronate Sodium; Cholecalciferol","TABLET;ORAL","021762","MERCK","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23"
"Fosrenol","Lanthanum Carbonate","TABLET, CHEWABLE;ORAL","021468","TAKEDA PHARMS USA","05/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021468s020,204734s001lbl.pdf#page=12"
"Fosrenol","Lanthanum Carbonate","TABLET, CHEWABLE;ORAL","021468","TAKEDA PHARMS USA","05/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021468s021,204734s003lbl.pdf#page=12"
"Fosrenol","Lanthanum Carbonate","POWDER;ORAL","204734","TAKEDA PHARMS USA","05/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf#page=12"
"Fosrenol","Lanthanum Carbonate","POWDER;ORAL","204734","TAKEDA PHARMS USA","05/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021468s021,204734s003lbl.pdf#page=12"
"Fosrenol","Lanthanum Carbonate","TABLET, CHEWABLE;ORAL","021468","TAKEDA PHARMS USA","05/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf#page=12"
"Fycompa","Perampanel","TABLET;ORAL","202834","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24"
"Fycompa","Perampanel","TABLET;ORAL","202834","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202834s012,208277s001lbl.pdf#page=24"
"Fycompa","Perampanel","SUSPENSION;ORAL","208277","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202834s012,208277s001lbl.pdf#page=24"
"Fycompa","Perampanel","TABLET;ORAL","202834","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202834s014,208277s002lbl.pdf#page=24"
"Fycompa","Perampanel","SUSPENSION;ORAL","208277","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202834s014,208277s002lbl.pdf#page=24"
"Fycompa","Perampanel","SUSPENSION;ORAL","208277","EISAI INC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24"
"Gabitril","Tiagabine Hydrochloride","TABLET;ORAL","020646","CEPHALON","08/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf"
"Gadavist","Gadobutrol","SOLUTION;INTRAVENOUS","201277","BAYER HLTHCARE","07/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201277s018lbl.pdf#page=22"
"Gattex Kit","Teduglutide Recombinant","POWDER;SUBCUTANEOUS","203441","NPS PHARMS INC","07/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203441s002lbl.pdf#page=10"
"Gattex Kit","Teduglutide Recombinant","POWDER;SUBCUTANEOUS","203441","NPS PHARMS INC","07/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203441s012lbl.pdf#page15"
"Gattex Kit","Teduglutide Recombinant","POWDER;SUBCUTANEOUS","203441","NPS PHARMS INC","07/14/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM333533.pdf"
"Gattex Kit","Teduglutide Recombinant","POWDER;SUBCUTANEOUS","203441","NPS PHARMS INC","07/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203441s013lbl.pdf#page=17"
"Gilenya","Fingolimod Hydrochloride","CAPSULE;ORAL","022527","NOVARTIS","12/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022527s029s030lbl.pdf#page=26"
"Gimoti","Metoclopramide Hydrochloride","SPRAY, METERED;NASAL","209388","EVOKE PHARMA INC","06/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209388s000lbl.pdf#page=17"
"Gloperba","Colchicine","SOLUTION;ORAL","210942","AVION PHARMS","01/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210942s000lbl.pdf#page=11"
"Glyxambi","Empagliflozin; Linagliptin","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206073s019lbl.pdf#page=32"
"Glyxambi","Empagliflozin; Linagliptin","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206073s022lbl.pdf#page=32"
"Glyxambi","Empagliflozin; Linagliptin","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206073s021lbl.pdf#page=33"
"Glyxambi","Empagliflozin; Linagliptin","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206073s012lbl.pdf#page=31"
"Glyxambi","Empagliflozin; Linagliptin","TABLET;ORAL","206073","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206073s023lbl.pdf#page=33"
"Golytely","Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate Anhydrous","FOR SOLUTION;ORAL","019011","BRAINTREE","06/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019011s031lbl.pdf#page=9"
"Golytely","Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate Anhydrous","FOR SOLUTION;ORAL","019011","BRAINTREE","06/05/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370635.pdf"
"Gralise","Gabapentin","TABLET;ORAL","022544","ALMATICA","04/02/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM245196.pdf"
"H.P. Acthar Gel","Repository Corticotropin","INJECTABLE; INJECTION","022432","QUESTCOR PHARMA","10/15/2010","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf"
"Hadlima","Adalimumab-Bwwd","INJECTABLE;INJECTION","761059","SAMSUNG BIOEPIS CO LTD","07/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf#page=36"
"Halcion","Triazolam","TABLET;ORAL","017892","PHARMACIA AND UPJOHN","10/09/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017892s050lbl.pdf#page=17"
"Halflytely","Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride","FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL","021551","BRAINTREE","06/03/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf"
"Hemlibra","Emicizumab","INJECTABLE;INJECTION","761083","GENENTECH INC","10/04/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761083s002s004lbl.pdf#page=21"
"Horizant","Gabapentin Enacarbil","TABLET, EXTENDED RELEASE;ORAL","022399","ARBOR PHARMS LLC","04/17/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM250398.pdf"
"Horizant","Gabapentin Enacarbil","TABLET, EXTENDED RELEASE;ORAL","022399","ARBOR PHARMS LLC","04/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27"
"Hulio","Adalimumab-Fkjp","INJECTABLE;INJECTION","761154","MYLAN PHARMS INC","07/06/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761154s000lbl.pdf#page=41"
"Humira","Adalimumab","VIAL","125057","ABBVIE INC","03/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125057s403lbl.pdf#page=53"
"Humira","Adalimumab","VIAL","125057","ABBVIE INC","03/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125057s409lbl.pdf#page=56"
"Humira","Adalimumab","SYRINGE","125057","ABBVIE INC","03/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125057s403lbl.pdf#page=53"
"Humira","Adalimumab","SYRINGE","125057","ABBVIE INC","03/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125057s409lbl.pdf#page=56"
"Hycodan","Homatropine METhylbromide; Hydrocodone Bitartrate","SYRUP;ORAL","005213","GENUS","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005213s039lbl.pdf#page=27"
"Hycodan","Homatropine METhylbromide; Hydrocodone Bitartrate","TABLET;ORAL","005213","GENUS","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005213s039lbl.pdf#page=27"
"Hydrea","Hydroxyurea","CAPSULE;ORAL","016295","BRISTOL MYERS SQUIBB","12/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016295s049s050lbl.pdf#page=15"
"Hydrea","Hydroxyurea","CAPSULE;ORAL","016295","BRISTOL MYERS SQUIBB","12/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016295s051lbl.pdf#page=27"
"Hydromorphone Hydrochloride","Hydromorphone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","204278","PADDOCK LLC","09/18/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf"
"Hyrimoz","Adalimumab-Adaz","INJECTABLE;INJECTION","761071","SANDOZ INC","10/30/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761071lbl.pdf#page=36"
"Hysingla ER","Hydrocodone Bitartrate","TABLET, EXTENDED RELEASE;ORAL","206627","PURDUE PHARMA LP","11/14/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206627s009MG.pdf"
"Hysingla ER","Hydrocodone Bitartrate","TABLET, EXTENDED RELEASE;ORAL","206627","PURDUE PHARMA LP","11/14/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206627s010lbl.pdf#page=37"
"Ibsrela","Tenapanor Hydrochloride","TABLET;ORAL","211801","ARDELYX INC","09/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211801s000lbl.pdf#page=13"
"Iclusig","Ponatinib Hydrochloride","TABLET;ORAL","203469","ARIAD","07/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203469s032lbl.pdf#page=29"
"Iclusig","Ponatinib Hydrochloride","TABLET;ORAL","203469","ARIAD","07/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203469s033lbl.pdf#page=29"
"Iclusig","Ponatinib Hydrochloride","TABLET;ORAL","203469","ARIAD","07/10/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203469s022lbl.pdf#page=24"
"Idhifa","Enasidenib Mesylate","TABLET;ORAL","209606","CELGENE CORP","09/27/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209606s000lbl.pdf#page=16"
"Idhifa","Enasidenib Mesylate","TABLET;ORAL","209606","CELGENE CORP","09/27/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209606s002lbl.pdf#page=16"
"Ilaris","Canakinumab","INJECTABLE; SUBCUTANEOUS","125319","NOVARTIS PHARMS","06/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125319s088lbl.pdf#page=20"
"Ilaris","Canakinumab","INJECTABLE; SUBCUTANEOUS","125319","NOVARTIS PHARMS","06/16/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM352352.pdf"
"Ilaris","Canakinumab","INJECTABLE; SUBCUTANEOUS","125319","NOVARTIS PHARMS","06/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125319s097lbl.pdf#page=21"
"Ilumya","Tildrakizumab-Asmn","INJECTABLE;INJECTION","761067","SUN PHARMA GLOBAL","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10"
"Imfinzi","Durvalumab","INJECTABLE;INJECTION","761069","ASTRAZENECA UK LTD","06/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761069s002lbl.pdf#page=24"
"Imfinzi","Durvalumab","INJECTABLE;INJECTION","761069","ASTRAZENECA UK LTD","06/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761069s018lbl.pdf#page=29"
"Imfinzi","Durvalumab","INJECTABLE;INJECTION","761069","ASTRAZENECA UK LTD","06/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761069s020lbl.pdf#page=30"
"Imipramine Hydrochloride","Imipramine Hydrochloride","TABLET;ORAL","087846","SPECGX LLC","06/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
"Incivek","Telaprevir","TABLET;ORAL","201917","VERTEX PHARMS","03/25/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf"
"Indocin","Indomethacin","CAPSULE;ORAL","016059","EGALET","03/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016059s100lbl.pdf#page=23"
"Indocin","Indomethacin","SUPPOSITORY;RECTAL","017814","EGALET","03/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017814s043lbl.pdf#page=23"
"Indocin","Indomethacin","SUSPENSION;ORAL","018332","EGALET","03/26/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088612.pdf"
"Indocin","Indomethacin","SUSPENSION;ORAL","018332","EGALET","03/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018332s040lbl.pdf#page=23"
"Indocin SR","Indomethacin","CAPSULE, EXTENDED RELEASE;ORAL","018185","EGALET","03/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018185s057lbl.pdf#page=23"
"Indocin SR","Indomethacin","CAPSULE, EXTENDED RELEASE;ORAL","018185","EGALET","03/26/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501640.pdf"
"Inflectra","Infliximab-Dyyb","INJECTABLE;INJECTION","125544","CELLTRION INC","06/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM497384.pdf"
"Inflectra","Infliximab-Dyyb","INJECTABLE;INJECTION","125544","CELLTRION INC","06/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125544s009lbl.pdf#page=59"
"Inrebic","Fedratinib Hydrochloride","CAPSULE;ORAL","212327","IMPACT","08/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf#page=22"
"Intermezzo","Zolpidem Tartrate","TABLET;SUBLINGUAL","022328","PURDUE PHARMA","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20"
"Intron A","Interferon Alfa-2b","VIAL","103132","SCHERING","05/04/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40"
"Invirase","Saquinavir Mesylate","TABLET;ORAL","021785","HOFFMANN-LA ROCHE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020628s046,021785s022lbl.pdf#page=25"
"Invirase","Saquinavir Mesylate","CAPSULE;ORAL","020628","HOFFMANN LA ROCHE","03/28/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229206.pdf"
"Invirase","Saquinavir Mesylate","CAPSULE;ORAL","020628","HOFFMANN LA ROCHE","03/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020628s046,021785s022lbl.pdf#page=25"
"Invirase","Saquinavir Mesylate","CAPSULE;ORAL","020628","HOFFMANN LA ROCHE","03/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24"
"Invirase","Saquinavir Mesylate","TABLET;ORAL","021785","HOFFMANN-LA ROCHE","12/19/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229206.pdf"
"Invirase","Saquinavir Mesylate","TABLET;ORAL","021785","HOFFMANN-LA ROCHE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24"
"Invirase","Saquinavir Mesylate","TABLET;ORAL","021785","HOFFMANN-LA ROCHE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021785s024lbl.pdf#page=26"
"Invokamet","Canagliflozin; METformin Hydrochloride","TABLET;ORAL","204353","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s033,205879s011lbl.pdf#page=59"
"Invokamet","Canagliflozin; METformin Hydrochloride","TABLET;ORAL","204353","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s039,205879s017lbl.pdf#page=58"
"Invokamet XR","Canagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205879","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s039,205879s017lbl.pdf#page=58"
"Invokamet XR","Canagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205879","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s033,205879s011lbl.pdf#page=59"
"Invokana","Canagliflozin","TABLET;ORAL","204042","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204042s034lbl.pdf#page=48"
"Invokana","Canagliflozin","TABLET;ORAL","204042","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204042s036lbl.pdf#page=49"
"Invokana","Canagliflozin","TABLET;ORAL","204042","JANSSEN PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204042s032lbl.pdf#page=49"
"Ixifi","Infliximab-Qbtx","INJECTABLE;INJECTION","761072","PFIZER INC","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761072s006lbl.pdf#page=43"
"Jadenu","Deferasirox","TABLET;ORAL","206910","NOVARTIS PHARMS CORP","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31"
"Jadenu","Deferasirox","TABLET;ORAL","206910","NOVARTIS PHARMS CORP","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206910s012lbl.pdf#page=29"
"Jadenu Sprinkle","Deferasirox","GRANULE;ORAL","207968","NOVARTIS","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31"
"Jadenu Sprinkle","Deferasirox","GRANULE;ORAL","207968","NOVARTIS","07/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207968s007lbl.pdf#page=29"
"Janumet","Metformin Hydrochloride; Sitagliptin Phosphate","TABLET;ORAL","022044","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022044s046lbl.pdf#page=33"
"Janumet","Metformin Hydrochloride; Sitagliptin Phosphate","TABLET;ORAL","022044","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022044s043lbl.pdf#page=32"
"Janumet","Metformin Hydrochloride; Sitagliptin Phosphate","TABLET;ORAL","022044","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022044s047lbl.pdf#page=32"
"Janumet XR","Metformin Hydrochloride; Sitagliptin Phosphate","TABLET, EXTENDED RELEASE;ORAL","202270","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202270s018lbl.pdf#page=32"
"Januvia","Sitagliptin Phosphate","TABLET;ORAL","021995","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021995s042lbl.pdf#page=24"
"Januvia","Sitagliptin Phosphate","TABLET;ORAL","021995","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s045lbl.pdf#page=27"
"Januvia","Sitagliptin Phosphate","TABLET;ORAL","021995","MERCK SHARP DOHME","08/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s046lbl.pdf#page=24"
"Jardiance","Empagliflozin","TABLET;ORAL","204629","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204629s023lbl.pdf#page=33"
"Jardiance","Empagliflozin","TABLET;ORAL","204629","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204629s018lbl.pdf#page=32"
"Jardiance","Empagliflozin","TABLET;ORAL","204629","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204629s019lbl.pdf#page=34"
"Jentadueto","Linagliptin; METformin Hydrochloride","TABLET;ORAL","201281","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201281s024lbl.pdf#page=22"
"Jentadueto","Linagliptin; METformin Hydrochloride","TABLET;ORAL","201281","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201281s025lbl.pdf#page=20"
"Jentadueto XR","Linagliptin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","208026","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208026s013lbl.pdf#page=20"
"Jentadueto XR","Linagliptin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","208026","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208026s012lbl.pdf#page=22"
"Jeuveau","Prabotulinumtoxina-Xvfs","INJECTABLE;INJECTION","761085","EVOLUS INC","07/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9"
"Jornay PM","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","209311","IRONSHORE PHARMS","05/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209311s003lbl.pdf#page=19"
"Jornay PM","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","209311","IRONSHORE PHARMS","05/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209311s000lbl.pdf#page=19"
"Juvisync","Simvastatin; Sitagliptin Phosphate","TABLET;ORAL","202343","MERCK SHARP DOHME","02/24/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf"
"Juxtapid","Lomitapide Mesylate","CAPSULE;ORAL","203858","AMRYT","12/20/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32"
"Jynarque","Tolvaptan","TABLET;ORAL","204441","OTSUKA PHARM CO LTD","12/03/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18"
"Kadian","Morphine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","020616","ALLERGAN","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020616s063lbl.pdf#page=34"
"Kalbitor","Ecallantide","INJECTABLE; INJECTION","125277","DYAX CORP.","09/08/2014","http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125277MedGuide.pdf"
"Kaletra","Lopinavir; Ritonavir","CAPSULE;ORAL","021226","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021226s047lbl.pdf#page=53"
"Kaletra","Lopinavir; Ritonavir","TABLET;ORAL","021906","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021251s058,021906s053lbl.pdf#page=52"
"Kaletra","Lopinavir; Ritonavir","SOLUTION;ORAL","021251","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021251s058,021906s053lbl.pdf#page=52"
"Kaletra","Lopinavir; Ritonavir","TABLET;ORAL","021906","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021251s055,021906s050lbl.pdf#page=51"
"Kaletra","Lopinavir; Ritonavir","CAPSULE;ORAL","021226","ABBVIE","12/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021226s048lbl.pdf#page=52"
"Kaletra","Lopinavir; Ritonavir","SOLUTION;ORAL","021251","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021251s055,021906s050lbl.pdf#page=51"
"Kaletra","Lopinavir; Ritonavir","CAPSULE;ORAL","021226","ABBVIE","12/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021226s045lbl.pdf#page=50"
"Kazano","Alogliptin Benzoate; METformin Hydrochloride","TABLET;ORAL","203414","TAKEDA PHARMS USA","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203414s007lbl.pdf#page=32"
"Kazano","Alogliptin Benzoate; METformin Hydrochloride","TABLET;ORAL","203414","TAKEDA PHARMS USA","07/01/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337729.pdf"
"Keppra","Levetiracetam","TABLET;ORAL","021035","UCB INC","10/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021035s102,021505s042lbl.pdf#page=32"
"Keppra","Levetiracetam","SOLUTION;ORAL","021505","UCB INC","10/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021035s102,021505s042lbl.pdf#page=32"
"Keppra XR","Levetiracetam","TABLET, EXTENDED RELEASE;ORAL","022285","UCB INC","10/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022285s028lbl.pdf#page=26"
"Kesimpta","Ofatumumab","INJECTABLE;INJECTION","125326","NOVARTIS","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125326s070lbl.pdf#page=13"
"Ketek","Telithromycin","TABLET;ORAL","021144","SANOFI AVENTIS US","11/04/2015","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29"
"Ketek","Telithromycin","TABLET;ORAL","021144","SANOFI AVENTIS US","11/04/2015","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088615.pdf"
"Kevzara","Sarilumab","INJECTABLE;INJECTION","761037","SANOFI SYNTHELABO","04/13/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761037s001lbl.pdf#page=27"
"Keytruda","Pembrolizumab","POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER","125514","MERCK SHARP DOHME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s067lbl.pdf#page=86"
"Keytruda","Pembrolizumab","POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER","125514","MERCK SHARP DOHME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s068lbl.pdf#page=87"
"Keytruda","Pembrolizumab","POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER","125514","MERCK SHARP DOHME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s071s090lbl.pdf#page=87"
"Keytruda","Pembrolizumab","POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER","125514","MERCK SHARP DOHME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s084lbl.pdf#page=89"
"Khedezla","Desvenlafaxine","TABLET, EXTENDED RELEASE;ORAL","204683","OSMOTICA PHARM CORP","01/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204683s005lbl.pdf#page=24"
"Khedezla","Desvenlafaxine","TABLET, EXTENDED RELEASE;ORAL","204683","OSMOTICA PHARM CORP","01/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204683s006lbl.pdf#page=24"
"Klonopin","Clonazepam","TABLET;ORAL","017533","ROCHE","10/25/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017533s059lbl.pdf#page=19"
"Klonopin Rapidly Disintegrating","Clonazepam","TABLET, ORALLY DISINTEGRATING;ORAL","020813","ROCHE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017533s058lbl.pdf#page=20"
"Kombiglyze XR","Metformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200678","ASTRAZENECA AB","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47"
"Kombiglyze XR","Metformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200678","ASTRAZENECA AB","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/200678s018lbl.pdf#page=47"
"Kombiglyze XR","Metformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200678","ASTRAZENECA AB","07/01/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280360.pdf"
"Korlym","Mifepristone","TABLET;ORAL","202107","CORCEPT THERAP","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202107s007lbl.pdf#page=19"
"Korlym","Mifepristone","TABLET;ORAL","202107","CORCEPT THERAP","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20"
"Krystexxa","Pegloticase","INJECTABLE; INJECTION","125293","HORIZON PHARMA","07/13/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125293s092lbl.pdf#page=14"
"Krystexxa","Pegloticase","INJECTABLE; INJECTION","125293","HORIZON PHARMA","07/13/2018","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM227568.pdf"
"Kynamro","Mipomersen Sodium","SOLUTION;SUBCUTANEOUS","203568","KASTLE THERAPS LLC","03/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf"
"Lacosamide","Lacosamide","SOLUTION;ORAL","204839","AMNEAL PHARMS","10/27/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf"
"Lacosamide","Lacosamide","TABLET;ORAL","204857","AMNEAL PHARMS NY","10/27/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf"
"Lacosamide","Lacosamide","TABLET;ORAL","204855","ACTAVIS LABS FL INC","10/27/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf"
"Lamictal","Lamotrigine","TABLET;ORAL","020241","GLAXOSMITHKLINE LLC","08/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf#page=64"
"Lamictal CD","Lamotrigine","TABLET, CHEWABLE;ORAL","020764","GLAXOSMITHKLINE LLC","08/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf#page=64"
"Lamictal ODT","Lamotrigine","TABLET, ORALLY DISINTEGRATING;ORAL","022251","GLAXOSMITHKLINE LLC","08/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf#page=64"
"Lamictal ODT","Lamotrigine","TABLET, ORALLY DISINTEGRATING;ORAL","022251","GLAXOSMITHKLINE LLC","08/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s056,020764s049,022251s020lbl.pdf#page=64"
"Lamictal XR","Lamotrigine","TABLET, EXTENDED RELEASE;ORAL","022115","GLAXOSMITHKLINE LLC","09/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022115s026lbl.pdf#page=50"
"Lamictal XR","Lamotrigine","TABLET, EXTENDED RELEASE; ORAL","022509","SMITHKLINE BEECHAM","01/29/2010","https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39"
"Lamisil","Terbinafine Hydrochloride","TABLET;ORAL","020539","NOVARTIS","03/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11"
"Lamisil","Terbinafine Hydrochloride","GRANULE;ORAL","022071","NOVARTIS","03/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10"
"Lamivudine, Nevirapine and Zidovudine","Lamivudine; Nevirapine; Zidovudine","TABLET;ORAL","205626","MICRO LABS","08/13/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50"
"Lariam","Mefloquine Hydrochloride","TABLET;ORAL","019591","ROCHE","04/29/2011","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088616.pdf"
"Lariam","Mefloquine Hydrochloride","TABLET;ORAL","019591","ROCHE","04/29/2011","https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13"
"Latuda","Lurasidone Hydrochloride","TABLET;ORAL","200603","SUNOVION PHARMS INC","12/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62"
"Lazanda","Fentanyl Citrate","SPRAY, METERED;NASAL","022569","BTCP PHARMA","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022569s024lbl.pdf#page=35"
"Lazanda","Fentanyl Citrate","SPRAY, METERED;NASAL","022569","BTCP PHARMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022569s027lbl.pdf#page=33"
"Lemtrada","Alemtuzumab","INJECTABLE;INJECTION","103948","GENZYME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103948s5169s5170lbl.pdf#page=28"
"Lemtrada","Alemtuzumab","INJECTABLE;INJECTION","103948","GENZYME","06/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103948s5173lbl.pdf#page=29"
"Letairis","Ambrisentan","TABLET;ORAL","022081","GILEAD","08/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26"
"Letairis","Ambrisentan","TABLET;ORAL","022081","GILEAD","08/23/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088617.pdf"
"Levaquin","Levofloxacin","TABLET;ORAL","020634","JANSSEN PHARMS","06/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s070lbl.pdf#page=52"
"Levaquin","Levofloxacin","TABLET;ORAL","020634","JANSSEN PHARMS","06/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54"
"Levaquin","Levofloxacin","INJECTABLE;INJECTION","020635","JANSSEN PHARMS","02/08/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088619.pdf"
"Levaquin","Levofloxacin","TABLET;ORAL","020634","JANSSEN PHARMS","06/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s069lbl.pdf#page=51"
"Levaquin","Levofloxacin","TABLET;ORAL","020634","JANSSEN PHARMS","06/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020634s071lbl.pdf#page=53"
"Levaquin","Levofloxacin","SOLUTION;ORAL","021721","JANSSEN PHARMS","02/08/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088619.pdf"
"Levaquin in Dextrose 5% in Plastic Container","Levofloxacin","INJECTABLE;INJECTION","020635","JANSSEN PHARMS","02/08/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088619.pdf"
"Lexapro","Escitalopram Oxalate","SOLUTION;ORAL","021365","ALLERGAN","01/11/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021323s047lbl.pdf#page=24"
"Lexapro","Escitalopram Oxalate","TABLET;ORAL","021323","ALLERGAN","01/11/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021323s047lbl.pdf#page=24"
"Librax","Chlordiazepoxide Hydrochloride; Clidinium Bromide","CAPSULE;ORAL","012750","BAUSCH","01/13/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/012750s065lbl.pdf#page=8"
"Librium","Chlordiazepoxide Hydrochloride","CAPSULE;ORAL","012249","VALEANT PHARM INTL","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8"
"Libtayo","Cemiplimab-Rwlc","INJECTABLE;INTRAVENOUS","761097","REGENERON PHARMACEUTICALS","06/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761097s005lbl.pdf#page=15"
"Licart","Diclofenac Epolamine","SYSTEM;TOPICAL","206976","IBSA INST BIO","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206976s002lbl.pdf#page=20"
"Licart","Diclofenac Epolamine","SYSTEM;TOPICAL","206976","IBSA INST BIO","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206976s000lbl.pdf#page=22"
"Limbitrol","Amitriptyline Hydrochloride; Chlordiazepoxide","TABLET;ORAL","016949","HERITAGE PHARMS INC","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016949s040lbl.pdf#page=12"
"Limbitrol DS","Amitriptyline Hydrochloride; Chlordiazepoxide","TABLET;ORAL","016949","HERITAGE PHARMS INC","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016949s040lbl.pdf#page=12"
"Lindane","Lindane","SHAMPOO;TOPICAL","087266","OLTA PHARMS","04/05/2004","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf"
"Lindane","Lindane","LOTION;TOPICAL","087313","OLTA PHARMS","09/04/2001","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf"
"Linzess","Linaclotide","CAPSULE;ORAL","202811","ALLERGAN","03/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202811s013lbl.pdf#page=20"
"Lithium Carbonate","Lithium Carbonate","TABLET;ORAL","018558","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.pdf#page=19"
"Lithium Carbonate","Lithium Carbonate","TABLET;ORAL","018558","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017812s034,018421s033,018558s028lbl.pdf#page=20"
"Lithium Carbonate","Lithium Carbonate","CAPSULE;ORAL","017812","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.pdf#page=19"
"Lithium Carbonate","Lithium Carbonate","CAPSULE;ORAL","017812","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s031,018421s031,018558s026lbl.pdf#page=19"
"Lithium Carbonate","Lithium Carbonate","CAPSULE;ORAL","017812","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017812s034,018421s033,018558s028lbl.pdf#page=20"
"Lithium Carbonate","Lithium Carbonate","TABLET;ORAL","018558","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s031,018421s031,018558s026lbl.pdf#page=19"
"Lithium Citrate","Lithium Citrate","SYRUP;ORAL","018421","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017812s034,018421s033,018558s028lbl.pdf#page=20"
"Lithium Citrate","Lithium Citrate","SYRUP;ORAL","018421","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s031,018421s031,018558s026lbl.pdf#page=19"
"Lithium Citrate","Lithium Citrate","SYRUP;ORAL","018421","HIKMA","02/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.pdf#page=19"
"Lotronex","Alosetron Hydrochloride","TABLET;ORAL","021107","SEBELA IRELAND LTD","04/03/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf"
"Lumoxiti","Moxetumomab Pasudotox-Tdfk","INJECTABLE;INJECTION","761104","ASTRAZENECA AB","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761104s000lbl.pdf#page=18"
"Lumoxiti","Moxetumomab Pasudotox-Tdfk","INJECTABLE;INJECTION","761104","ASTRAZENECA AB","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s001lbl.pdf#page=18"
"Lumoxiti","Moxetumomab Pasudotox-Tdfk","INJECTABLE;INJECTION","761104","ASTRAZENECA AB","08/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18"
"Lunesta","Eszopiclone","TABLET;ORAL","021476","SUNOVION PHARMS INC","08/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM134691.pdf"
"Lunesta","Eszopiclone","TABLET;ORAL","021476","SUNOVION PHARMS INC","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26"
"Lupron","Leuprolide Acetate","INJECTABLE;INJECTION","019010","ABBVIE ENDOCRINE INC","12/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27"
"Lupron Depot-Ped Kit","Leuprolide Acetate","POWDER;INTRAMUSCULAR","020263","ABBVIE ENDOCRINE INC","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020263s046lbl.pdf#page=21"
"Lupron Depot-Ped Kit","Leuprolide Acetate","POWDER;INTRAMUSCULAR","020263","ABBVIE ENDOCRINE INC","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020263s042lbl.pdf#page=20"
"Luvox","Fluvoxamine Maleate","TABLET;ORAL","021519","ANI PHARMS","12/16/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021519s009lbl.pdf#page=30"
"Luvox","Fluvoxamine Maleate","TABLET;ORAL","021519","ANI PHARMS","12/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021519s012lbl.pdf#page=32"
"Luvox","Fluvoxamine Maleate","TABLET; ORAL","022235","JAZZ","04/14/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM249169.pdf"
"Luvox CR","Fluvoxamine Maleate","CAPSULE, EXTENDED RELEASE;ORAL","022033","JAZZ PHARMS","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s013lbl.pdf#page=41"
"Lynparza","Olaparib","CAPSULE;ORAL","206162","ASTRAZENECA PHARMS","09/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206162s008lbl.pdf#page=16"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208558s005lbl.pdf#page=27"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208558s000lbl.pdf#page=23"
"Lynparza","Olaparib","CAPSULE;ORAL","206162","ASTRAZENECA PHARMS","09/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208558s010lbl.pdf#page=37"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208558s009lbl.pdf#page=32"
"Lynparza","Olaparib","TABLET;ORAL","208558","ASTRAZENECA PHARMS","05/19/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf#page=50"
"Lyrica","Pregabalin","CAPSULE;ORAL","021446","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf#page=54"
"Lyrica","Pregabalin","CAPSULE;ORAL","021446","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf#page=56"
"Lyrica","Pregabalin","SOLUTION;ORAL","022488","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf#page=54"
"Lyrica","Pregabalin","SOLUTION;ORAL","022488","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf#page=56"
"Lyrica","Pregabalin","CAPSULE;ORAL","021446","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021446s032,022488s011lbl.pdf#page=50"
"Lyrica CR","Pregabalin","TABLET, EXTENDED RELEASE;ORAL","209501","PFIZER","04/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf#page=29"
"Magnevist","Gadopentetate Dimeglumine","INJECTABLE;INJECTION","021037","BAYER HLTHCARE","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13"
"Magnevist","Gadopentetate Dimeglumine","INJECTABLE;INJECTION","019596","BAYER HLTHCARE","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12"
"Marplan","Isocarboxazid","TABLET;ORAL","011961","VALIDUS PHARMS INC","11/08/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16"
"Mavenclad","Cladribine","TABLET;ORAL","022561","EMD SERONO INC","03/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022561s000lbl.pdf#page=29"
"Mayzent","Siponimod Fumaric Acid","TABLET;ORAL","209884","NOVARTIS","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209884s000lbl.pdf#page=22"
"Meridia","Sibutramine Hydrochloride","CAPSULE;ORAL","020632","ABBOTT","08/04/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf"
"Metadate CD","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021259","LANNETT CO INC","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021259s030lbl.pdf#page=20"
"Methylin","Methylphenidate Hydrochloride","TABLET, CHEWABLE;ORAL","021475","SPECGX LLC","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021475s010lbl.pdf#page=13"
"Methylin","Methylphenidate Hydrochloride","SOLUTION;ORAL","021419","SPECGX LLC","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021419s014lbl.pdf#page=12"
"Metoclopramide Hydrochloride","Metoclopramide Hydrochloride","SOLUTION;ORAL","074703","WOCKHARDT BIO AG","04/08/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf"
"Metozolv ODT","Metoclopramide Hydrochloride","TABLET, ORALLY DISINTEGRATING;ORAL","022246","SALIX PHARMS","02/28/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187064.pdf"
"Metozolv ODT","Metoclopramide Hydrochloride","TABLET, ORALLY DISINTEGRATING;ORAL","022246","SALIX PHARMS","02/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18"
"Mifeprex","Mifepristone","TABLET;ORAL","020687","DANCO LABS LLC","04/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020687s022lbl.pdf#page=16"
"Mifeprex","Mifepristone","TABLET;ORAL","020687","DANCO LABS LLC","04/11/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088643.pdf"
"Mircera","Methoxy Polyethylene Glycol-Epoetin Beta","SOLUTION; INJECTION","125164","HOFFMAN-LA ROCHE","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125164s078lbl.pdf#page=23"
"Mitigare","Colchicine","CAPSULE;ORAL","204820","HIKMA INTL PHARMS","09/26/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf"
"Mobic","Meloxicam","TABLET;ORAL","020938","BOEHRINGER INGELHEIM","06/30/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088646.pdf"
"Mobic","Meloxicam","SUSPENSION;ORAL","021530","AVONDALE PHARMS","09/01/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088646.pdf"
"Morphabond ER","Morphine Sulfate","TABLET, EXTENDED RELEASE;ORAL","206544","DAIICHI SANKYO INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38"
"Morphine Sulfate","Morphine Sulfate","TABLET;ORAL","022207","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022207s009lbl.pdf#page=26"
"Morphine Sulfate","Morphine Sulfate","SOLUTION;ORAL","022195","HIKMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022195s018lbl.pdf#page=28"
"Morphine Sulfate","Morphine Sulfate","SOLUTION;ORAL","201517","LANNETT CO INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201517s015lbl.pdf#page=28"
"Motrin","Ibuprofen","TABLET;ORAL","017463","MCNEIL CONSUMER","09/10/2007","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088647.pdf"
"Movantik","Naloxegol Oxalate","TABLET;ORAL","204760","REDHILL","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204760s007lbl.pdf#page=16"
"Movantik","Naloxegol Oxalate","TABLET;ORAL","204760","REDHILL","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204760s008lbl.pdf#page=16"
"Movantik","Naloxegol Oxalate","TABLET;ORAL","204760","REDHILL","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16"
"Moviprep","Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate","FOR SOLUTION;ORAL","021881","SALIX PHARMS","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021881s017lbl.pdf#page=13"
"Moviprep","Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate","FOR SOLUTION;ORAL","021881","SALIX PHARMS","11/05/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM253840.pdf"
"Moxifloxacin Hydrochloride","Moxifloxacin Hydrochloride","SOLUTION;INTRAVENOUS","205572","FRESENIUS KABI USA","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49"
"Moxifloxacin Hydrochloride","Moxifloxacin Hydrochloride","SOLUTION;INTRAVENOUS","205572","FRESENIUS KABI USA","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205572s006lbl.pdf#page=49"
"Moxifloxacin Hydrochloride","Moxifloxacin Hydrochloride","SOLUTION;INTRAVENOUS","205572","FRESENIUS KABI USA","03/27/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM088619.pdf"
"MS Contin","Morphine Sulfate","TABLET, EXTENDED RELEASE;ORAL","019516","PURDUE PHARMA LP","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019516s055lbl.pdf#page=27"
"Multaq","Dronedarone Hydrochloride","TABLET;ORAL","022425","SANOFI AVENTIS US","02/12/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM171764.pdf"
"Multaq","Dronedarone Hydrochloride","TABLET;ORAL","022425","SANOFI AVENTIS US","02/12/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022425s025lbl.pdf#page=22"
"Multihance","Gadobenate Dimeglumine","INJECTABLE;INTRAVENOUS","021357","BRACCO","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s016s017,021358s015s016lbl.pdf#page=34"
"Multihance Multipack","Gadobenate Dimeglumine","INJECTABLE;INTRAVENOUS","021358","BRACCO","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s016s017,021358s015s016lbl.pdf#page=34"
"Myalept","Metreleptin","INJECTABLE;INJECTION","125390","AEGERION","07/13/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125390s010lbl.pdf#page=14"
"Mydayis","Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate","CAPSULE, EXTENDED RELEASE;ORAL","022063","TAKEDA PHARMS USA","09/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022063s001lbl.pdf#page=22"
"Myfortic","Mycophenolic Acid","TABLET, DELAYED RELEASE;ORAL","050791","NOVARTIS","04/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050791s024lbl.pdf#page=25"
"Myfortic","Mycophenolic Acid","TABLET, DELAYED RELEASE;ORAL","050791","NOVARTIS","04/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050791s030lbl.pdf#page=24"
"Myfortic","Mycophenolic Acid","TABLET, DELAYED RELEASE;ORAL","050791","NOVARTIS","04/28/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM172735.pdf"
"Myobloc","Botulinum Toxin Type B","VIAL","103846","ELAN PHARM","08/20/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103846s5190lbl.pdf#page=18"
"Mysoline","Primidone","TABLET;ORAL","009170","VALEANT","02/19/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009170s035MedGuide.pdf"
"Nalfon","Fenoprofen Calcium","CAPSULE;ORAL","017604","XSPIRE PHARMA","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088655.pdf"
"Naprelan","Naproxen Sodium","TABLET, EXTENDED RELEASE;ORAL","020353","ALVOGEN","07/22/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280324.pdf"
"Naprelan","Naproxen Sodium","TABLET, EXTENDED RELEASE;ORAL","020353","ALVOGEN","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020353s036lbl.pdf#page=21"
"Naprosyn","Naproxen","TABLET;ORAL","017581","ATNAHS PHARMA US","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017581s114,018164s064,020067s021lbl.pdf#page=22"
"Naprosyn","Naproxen","SUSPENSION;ORAL","018965","ATNAHS PHARMA US","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018965s025lbl.pdf#page=21"
"Nardil","Phenelzine Sulfate","TABLET;ORAL","011909","PARKE DAVIS","08/02/2007","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf"
"Natpara","Parathyroid Hormone","INJECTABLE;INJECTION","125511","NPS PHARMS INC","07/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/natparaMedGuide.pdf"
"Natpara","Parathyroid Hormone","INJECTABLE;INJECTION","125511","NPS PHARMS INC","07/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s014lbl.pdf#page=18"
"Natpara","Parathyroid Hormone","INJECTABLE;INJECTION","125511","NPS PHARMS INC","07/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18"
"Nayzilam","Midazolam","SPRAY;NASAL","211321","UCB INC","05/17/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211321s000lbl.pdf#page=24"
"Nerlynx","Neratinib Maleate","TABLET;ORAL","208051","PUMA BIOTECH","07/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208051s002lbl.pdf#page=19"
"Nesina","Alogliptin Benzoate","TABLET;ORAL","022271","TAKEDA PHARMS USA","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022271s012lbl.pdf#page=29"
"Nesina","Alogliptin Benzoate","TABLET;ORAL","022271","TAKEDA PHARMS USA","07/01/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337732.pdf"
"Neurontin","Gabapentin","SOLUTION;ORAL","021129","UPJOHN","04/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s062,020882s045,021129s044lbl.pdf#page=32"
"Neurontin","Gabapentin","CAPSULE;ORAL","020235","UPJOHN","04/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s062,020882s045,021129s044lbl.pdf#page=32"
"Neurontin","Gabapentin","TABLET;ORAL","020882","UPJOHN","04/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s062,020882s045,021129s044lbl.pdf#page=32"
"Nexium","Esomeprazole Magnesium","FOR SUSPENSION, DELAYED RELEASE;ORAL","021957","ASTRAZENECA PHARMS","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021153s053,022101s017,021957s020lbl.pdf#page=33"
"Nexium","Esomeprazole Magnesium","CAPSULE, DELAYED REL PELLETS;ORAL","021153","ASTRAZENECA PHARMS","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021153s053,022101s017,021957s020lbl.pdf#page=33"
"Nexium","Esomeprazole Magnesium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022101","ASTRAZENECA PHARMS","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021153s053,022101s017,021957s020lbl.pdf#page=33"
"Nizoral","Ketoconazole","TABLET;ORAL","018533","JANSSEN PHARMS","02/25/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM362592.pdf"
"Nocdurna","Desmopressin Acetate","TABLET;SUBLINGUAL","022517","FERRING PHARMS INC","06/21/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14"
"Noctiva","Desmopressin Acetate","SPRAY, METERED;NASAL","201656","ALYVANT","03/03/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13"
"Nolvadex","Tamoxifen Citrate","TABLET;ORAL","017970","ASTRAZENECA","03/13/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf"
"Noroxin","Norfloxacin","TABLET;ORAL","019384","MERCK","07/26/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf"
"Norpramin","Desipramine Hydrochloride","TABLET;ORAL","014399","US PHARM HOLDINGS","11/09/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf"
"Novantrone","Mitoxantrone Hydrochloride","INJECTABLE;INJECTION","019297","EMD SERONO","03/23/2012","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf"
"Nplate","Romiplostim","INJECTABLE; SUBCUTANEOUS","125268","AMGEN","10/17/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125268s164lbl.pdf#page=16"
"Nucynta","Tapentadol Hydrochloride","TABLET;ORAL","022304","COLLEGIUM PHARM INC","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022304s016lbl.pdf#page=32"
"Nucynta","Tapentadol Hydrochloride","TABLET;ORAL","022304","COLLEGIUM PHARM INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022304s019s021lbl.pdf#page=32"
"Nucynta","Tapentadol Hydrochloride","SOLUTION;ORAL","203794","COLLEGIUM PHARM INC","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203794s000mg.pdf"
"Nucynta","Tapentadol Hydrochloride","SOLUTION;ORAL","203794","COLLEGIUM PHARM INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203794s008lbl.pdf#page=35"
"Nucynta","Tapentadol Hydrochloride","TABLET;ORAL","022304","COLLEGIUM PHARM INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022304s022lbl.pdf#page=33"
"Nucynta ER","Tapentadol Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","200533","COLLEGIUM PHARM INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200533s020lbl.pdf#page=34"
"Nulojix","Belatacept","INJECTABLE; INJECTION","125288","BRISTOL MYERS SQUIBB","04/13/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49"
"Nulytely","Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride","FOR SOLUTION;ORAL","019797","BRAINTREE","09/23/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"
"Nulytely-Flavored","Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride","FOR SOLUTION;ORAL","019797","BRAINTREE","09/23/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf"
"Nuvigil","Armodafinil","TABLET;ORAL","021875","CEPHALON","02/07/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231717.pdf"
"Obredon","Guaifenesin; Hydrocodone Bitartrate","SOLUTION;ORAL","205474","SOVEREIGN PHARMS","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205474s005lbl.pdf#page=23"
"Ocaliva","Obeticholic Acid","TABLET;ORAL","207999","INTERCEPT PHARMS INC","02/01/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207999s003lbl.pdf#page=23"
"Ocrevus","Ocrelizumab","INJECTABLE;INJECTION","761053","GENENTECH INC","05/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf#page=17"
"Ocrevus","Ocrelizumab","INJECTABLE;INJECTION","761053","GENENTECH INC","05/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761053s020lbl.pdf#page=17"
"Ocrevus","Ocrelizumab","INJECTABLE;INJECTION","761053","GENENTECH INC","05/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761053s024lbl.pdf#page=18"
"Odomzo","Sonidegib Phosphate","CAPSULE;ORAL","205266","SUN PHARMA GLOBAL","05/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205266Orig1s000lbl.pdf#page=12"
"Odomzo","Sonidegib Phosphate","CAPSULE;ORAL","205266","SUN PHARMA GLOBAL","05/13/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205266s002lbl.pdf#page=12"
"Odomzo","Sonidegib Phosphate","CAPSULE;ORAL","205266","SUN PHARMA GLOBAL","05/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205266s006lbl.pdf#page=13"
"Oleptro","Trazodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022411","ANGELINI PHARMA","07/17/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf"
"Olumiant","Baricitinib","TABLET;ORAL","207924","ELI LILLY AND CO","07/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207924s002lbl.pdf#page=18"
"Olumiant","Baricitinib","TABLET;ORAL","207924","ELI LILLY AND CO","07/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207924s001lbl.pdf#page=18"
"Omniscan","Gadodiamide","INJECTABLE;INJECTION","022066","GE HEALTHCARE","10/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1"
"Omniscan","Gadodiamide","INJECTABLE;INJECTION","020123","GE HEALTHCARE","11/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1"
"Omontys","Peginesatide Acetate","SOLUTION;INTRAVENOUS, SUBCUTANEOUS","202799","TAKEDA PHARMS USA","12/04/2012","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM297877.pdf"
"Omontys Preservative Free","Peginesatide Acetate","SOLUTION;INTRAVENOUS, SUBCUTANEOUS","202799","TAKEDA PHARMS USA","12/04/2012","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM297877.pdf"
"Onfi","Clobazam","TABLET;ORAL","202067","LUNDBECK PHARMS LLC","06/15/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202067s005,203993s007lbl.pdf#page=29"
"Onfi","Clobazam","SUSPENSION;ORAL","203993","LUNDBECK PHARMS LLC","06/15/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202067s005,203993s007lbl.pdf#page=29"
"Onglyza","Saxagliptin Hydrochloride","TABLET;ORAL","022350","ASTRAZENECA AB","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31"
"Onglyza","Saxagliptin Hydrochloride","TABLET;ORAL","022350","ASTRAZENECA AB","07/01/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022350s018lbl.pdf#page=31"
"Onsolis","Fentanyl Citrate","FILM;BUCCAL","022266","BDSI","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022266s023lbl.pdf#page=32"
"Opana","Oxymorphone Hydrochloride","TABLET;ORAL","021611","ENDO PHARMS","10/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27"
"Opana ER","Oxymorphone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","201655","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26"
"Opana ER","Oxymorphone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021610","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021610s027lbl.pdf#page=26"
"Opdivo","Nivolumab","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s078lbl.pdf#page=80"
"Opdivo","Nivolumab","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s081lbl.pdf#page=95"
"Opdivo","Nivolumab","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125554s075lbl.pdf#page=75"
"Opdivo","Nivolumab","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s083lbl.pdf#page=95"
"Opdivo","Nivolumab","INJECTABLE;INJECTION","125554","BRISTOL MYERS SQUIBB","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s082lbl.pdf#page=90"
"Opsumit","Macitentan","TABLET;ORAL","204410","ACTELION PHARMS LTD","04/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204410s010lbl.pdf#page=20"
"Optimark","Gadoversetamide","INJECTABLE;INJECTION","020937","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s027lbl.pdf#page=13"
"Optimark","Gadoversetamide","INJECTABLE;INJECTION","020975","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=29"
"Optimark","Gadoversetamide","INJECTABLE;INJECTION","020937","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14"
"Optimark","Gadoversetamide","INJECTABLE;INJECTION","020975","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13"
"Optimark in Plastic Container","Gadoversetamide","INJECTABLE;INJECTION","020976","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=43"
"Optimark in Plastic Container","Gadoversetamide","INJECTABLE;INJECTION","020976","LIEBEL-FLARSHEIM","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13"
"Oriahnn (Copackaged)","Elagolix Sodium,Estradiol,Norethindrone Acetate; Elagolix Sodium","CAPSULE;ORAL","213388","ABBVIE INC","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213388s000lbl.pdf#page=29"
"Orilissa","Elagolix Sodium","TABLET;ORAL","210450","ABBVIE INC","08/28/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210450s002lbl.pdf#page=27"
"Oseni","Alogliptin Benzoate; Pioglitazone Hydrochloride","TABLET;ORAL","022426","TAKEDA PHARMS USA","07/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43"
"Oseni","Alogliptin Benzoate; Pioglitazone Hydrochloride","TABLET;ORAL","022426","TAKEDA PHARMS USA","07/01/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022426s009lbl.pdf#page=42"
"Osmoprep","Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate","TABLET;ORAL","021892","SALIX PHARMS","11/29/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006mg.pdf"
"Osmoprep","Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate","TABLET;ORAL","021892","SALIX PHARMS","11/29/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13"
"Oxaydo","Oxycodone Hydrochloride","TABLET;ORAL","202080","ZYLA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202080s009s010lbl.pdf#page=27"
"Oxaydo","Oxycodone Hydrochloride","TABLET;ORAL","202080","ZYLA","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202080s005s006lbl.pdf#page=26"
"Oxaydo","Oxycodone Hydrochloride","TABLET;ORAL","202080","ZYLA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202080s011lbl.pdf#page=29"
"Oxtellar XR","Oxcarbazepine","TABLET, EXTENDED RELEASE;ORAL","202810","SUPERNUS PHARMS","12/13/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202810s000mg.pdf"
"Oxycodone Hydrochloride","Oxycodone Hydrochloride","SOLUTION;ORAL","201194","VISTAPHARM","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201194s008lbl.pdf#page=30"
"Oxycodone Hydrochloride","Oxycodone Hydrochloride","CAPSULE;ORAL","200534","GENUS LIFESCIENCES","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200534s009lbl.pdf#page=29"
"Oxycodone Hydrochloride","Oxycodone Hydrochloride","SOLUTION;ORAL","200535","GENUS LIFESCIENCES","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200535s000MedGuide.pdf"
"Oxycodone Hydrochloride","Oxycodone Hydrochloride","SOLUTION;ORAL","200535","GENUS LIFESCIENCES","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200535s016lbl.pdf#page=32"
"Oxycontin","Oxycodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022272","PURDUE PHARMA LP","11/14/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022272s043lbl.pdf#page=47"
"Oxycontin","Oxycodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022272","PURDUE PHARMA LP","11/14/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022272s042MG.pdf"
"Oxymorphone Hydrochloride","Oxymorphone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","079046","ACTAVIS ELIZABETH","10/10/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf"
"Ozempic","Semaglutide","SOLUTION;SUBCUTANEOUS","209637","NOVO","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209637s004lbl.pdf#page=24"
"Ozempic","Semaglutide","SOLUTION;SUBCUTANEOUS","209637","NOVO","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf#page=24"
"Pacerone","Amiodarone Hydrochloride","TABLET;ORAL","075135","UPSHER SMITH LABS","11/01/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf"
"Palladone","Hydromorphone Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021044","PURDUE PHARMA LP","04/16/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf"
"Palynziq","Pegvaliase-Pqpz","INJECTABLE;INJECTION","761079","BIOMARIN PHARM","05/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23"
"Pamelor","Nortriptyline Hydrochloride","CAPSULE;ORAL","018013","SPECGX LLC","04/09/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf"
"Pamelor","Nortriptyline Hydrochloride","CAPSULE;ORAL","018013","SPECGX LLC","04/09/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15"
"Pamelor","Nortriptyline Hydrochloride","SOLUTION;ORAL","018012","SPECGX LLC","07/28/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf"
"Pancreaze","Pancrelipase (Amylase;Lipase;Protease)","CAPSULE, DELAYED RELEASE;ORAL","022523","VIVUS INC","03/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16"
"Parnate","Tranylcypromine Sulfate","TABLET;ORAL","012342","CONCORDIA","01/04/2018","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088674.pdf"
"Paxil","Paroxetine Hydrochloride","TABLET;ORAL","020031","APOTEX TECHNOLOGIES","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020031s074lbl.pdf#page=43"
"Paxil","Paroxetine Hydrochloride","SUSPENSION;ORAL","020710","APOTEX TECHNOLOGIES","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020031s074lbl.pdf#page=43"
"Paxil CR","Paroxetine Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","020936","APOTEX TECHNOLOGIES","09/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020936s047lbl.pdf#page=29"
"Peganone","Ethotoin","TABLET;ORAL","010841","RECORDATI RARE","02/27/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf"
"Pegasys","Peginterferon Alfa-2a","VIAL; SUBCUTANEOUS","103964","HOFFMAN-LA ROCHE","10/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103964s5270lbl.pdf#page=39"
"Pegasys","Peginterferon Alfa-2a","SYRINGE","103964","HOFFMAN-LA ROCHE","10/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103964s5270lbl.pdf#page=39"
"Pegintron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5311lbl.pdf#page=27"
"Pegintron","Peginterferon Alfa-2b","SYRINGE","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13"
"Pegintron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13"
"Pegintron","Peginterferon Alfa-2b","SYRINGE","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29"
"Pegintron","Peginterferon Alfa-2b","SYRINGE","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5311lbl.pdf#page=27"
"Pegintron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29"
"Pennsaid","Diclofenac Sodium","SOLUTION;TOPICAL","020947","NUVO PHARMS INC","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf"
"Percocet","Acetaminophen; Oxycodone Hydrochloride","TABLET;ORAL","040330","VINTAGE PHARMS LLC","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf"
"Percodan","Aspirin; Oxycodone Hydrochloride","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/007337s049lbl.pdf#page=24"
"Percodan","Aspirin; Oxycodone Hydrochloride","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/007337s052lbl.pdf#page=26"
"Percodan","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/007337s050s051lbl.pdf#page=25"
"Percodan","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/007337s052lbl.pdf#page=26"
"Percodan","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/007337s049lbl.pdf#page=24"
"Percodan","Aspirin; Oxycodone Hydrochloride","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/007337s050s051lbl.pdf#page=25"
"Percodan-Demi","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/007337s049lbl.pdf#page=24"
"Percodan-Demi","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/007337s050s051lbl.pdf#page=25"
"Percodan-Demi","Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate","TABLET;ORAL","007337","ENDO PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/007337s052lbl.pdf#page=26"
"Perforomist","Formoterol Fumarate","SOLUTION;INHALATION","022007","MYLAN SPECLT","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19"
"Perforomist","Formoterol Fumarate","SOLUTION;INHALATION","022007","MYLAN SPECLT","05/29/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM214444.pdf"
"Pexeva","Paroxetine Mesylate","TABLET;ORAL","021299","SEBELA IRELAND LTD","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021299s033lbl.pdf#page=38"
"Phenergan VC W/ Codeine","Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride","SYRUP;ORAL","008306","ANI PHARMS","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/008306s034lbl.pdf#page=29"
"Phenergan W/ Codeine","Codeine Phosphate; Promethazine Hydrochloride","SYRUP;ORAL","008306","ANI PHARMS","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/008306s034lbl.pdf#page=29"
"Plavix","Clopidogrel Bisulfate","TABLET;ORAL","020839","SANOFI AVENTIS US","05/17/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020839s070lbl.pdf#page=23"
"Plavix","Clopidogrel Bisulfate","TABLET;ORAL","020839","SANOFI AVENTIS US","05/17/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020839s072lbl.pdf#page=24"
"Plegridy","Peginterferon Beta-1a","INJECTABLE;INJECTION","125499","BIOGEN IDEC INC","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125499s018lbl.pdf#page=19"
"Plegridy","Peginterferon Beta-1a","INJECTABLE;INJECTION","125499","BIOGEN IDEC INC","03/27/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM475804.pdf"
"Plenvu","Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate","FOR SOLUTION;ORAL","209381","SALIX","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209381s002lbl.pdf#page=17"
"Plenvu","Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate","FOR SOLUTION;ORAL","209381","SALIX","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209381s000lbl.pdf#page=17"
"Plenvu","Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate","FOR SOLUTION;ORAL","209381","SALIX","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209381s001lbl.pdf#page=17"
"Pomalyst","Pomalidomide","CAPSULE;ORAL","204026","CELGENE","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s024lbl.pdf#page=33"
"Pomalyst","Pomalidomide","CAPSULE;ORAL","204026","CELGENE","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s023lbl.pdf#page=33"
"Pomalyst","Pomalidomide","CAPSULE;ORAL","204026","CELGENE","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204026s021lbl.pdf#page=31"
"Pomalyst","Pomalidomide","CAPSULE;ORAL","204026","CELGENE","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204026s017lbl.pdf#page=31"
"Ponstel","Mefenamic Acid","CAPSULE;ORAL","015034","AVION PHARMS","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088692.pdf"
"Potiga","Ezogabine","TABLET;ORAL","022345","GLAXOSMITHKLINE","05/20/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf"
"Pradaxa","Dabigatran Etexilate Mesylate","CAPSULE;ORAL","022512","BOEHRINGER INGELHEIM","07/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022512s039lbl.pdf#page=24"
"Prepopik","Citric Acid; Magnesium Oxide; Sodium Picosulfate","FOR SOLUTION;ORAL","202535","FERRING PHARMS INC","08/15/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202535s005lbl.pdf#page=15"
"Pretomanid","Pretomanid","TABLET;ORAL","212862","MYLAN IRELAND LTD","08/14/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212862s000lbl.pdf#page=19"
"Prevacid","Lansoprazole","TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL","021428","TAKEDA PHARMS USA","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf#page=38"
"Prevacid","Lansoprazole","CAPSULE, DELAYED REL PELLETS;ORAL","020406","TAKEDA PHARMS USA","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf#page=38"
"Prevacid Naprapac 250 (Copackaged)","Lansoprazole; Naproxen","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"Prevacid Naprapac 375 (Copackaged)","Lansoprazole; Naproxen","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"Prevacid Naprapac 500 (Copackaged)","Lansoprazole; Naproxen","CAPSULE, DELAYED REL PELLETS, TABLET;ORAL","021507","TAKEDA PHARMS NA","07/31/2009","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf"
"Priftin","Rifapentine","TABLET;ORAL","021024","SANOFI AVENTIS US","06/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28"
"Priftin","Rifapentine","TABLET;ORAL","021024","SANOFI AVENTIS US","06/09/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM426514.pdf"
"Prilosec","Omeprazole","CAPSULE, DELAYED REL PELLETS;ORAL","019810","ASTRAZENECA PHARMS","12/19/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf"
"Prilosec","Omeprazole","CAPSULE, DELAYED REL PELLETS;ORAL","019810","ASTRAZENECA PHARMS","12/19/2016","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34"
"Prilosec","Omeprazole Magnesium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022056","COVIS PHARMA BV","08/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf#page=34"
"Prilosec","Omeprazole Magnesium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022056","COVIS PHARMA BV","08/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022056s021lbl.pdf#page=14"
"Prilosec","Omeprazole Magnesium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022056","COVIS PHARMA BV","08/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34"
"Prilosec","Omeprazole","CAPSULE, DELAYED REL PELLETS;ORAL","019810","ASTRAZENECA PHARMS","12/19/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM322359.pdf"
"Pristiq","Desvenlafaxine Succinate","TABLET, EXTENDED RELEASE;ORAL","021992","PF PRISM CV","02/06/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021992s046lbl.pdf#page=35"
"Probuphine","Buprenorphine Hydrochloride","IMPLANT;IMPLANTATION","204442","TITAN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204442s009lbl.pdf#page=49"
"Prohance","Gadoteridol","INJECTABLE;INJECTION","020131","BRACCO","04/26/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020131s028lbl.pdf#page=1"
"Prohance Multipack","Gadoteridol","INJECTABLE;INJECTION","021489","BRACCO","11/02/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021489s006lbl.pdf#page=1"
"Prolia","Denosumab","INJECTABLE; SUBCUTANEOUS","125320","AMGEN","06/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125320s205lbl.pdf#page=30"
"Prolia","Denosumab","INJECTABLE; SUBCUTANEOUS","125320","AMGEN","06/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125320s202lbl.pdf#page=30"
"Promacta","Eltrombopag Olamine","TABLET;ORAL","022291","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022291s021lbl.pdf#page=35"
"Promacta","Eltrombopag Olamine","TABLET;ORAL","022291","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022291s027,207027s010lbl.pdf#page=35"
"Promacta Kit","Eltrombopag Olamine","FOR SUSPENSION;ORAL","207027","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022291s027,207027s010lbl.pdf#page=35"
"Promacta Kit","Eltrombopag Olamine","FOR SUSPENSION;ORAL","207027","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207027s008lbl.pdf#page=35"
"Propulsid","Cisapride Monohydrate","TABLET;ORAL","020210","JANSSEN PHARMS","03/06/2000","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf"
"Propylthiouracil","Propylthiouracil","TABLET;ORAL","006188","DAVA PHARMS INC","09/19/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/006188s020MedGuide.pdf"
"Propylthiouracil","Propylthiouracil","TABLET;ORAL","006188","DAVA PHARMS INC","09/19/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7"
"Proquin XR","Ciprofloxacin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021744","DEPOMED INC","08/15/2011","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf"
"Protonix","Pantoprazole Sodium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022020","WYETH PHARMS","04/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020987s055,022020s017lbl.pdf#page=33"
"Protonix","Pantoprazole Sodium","FOR SUSPENSION, DELAYED RELEASE;ORAL","022020","WYETH PHARMS","04/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020987s053,022020s015lbl.pdf#page=30"
"Protonix","Pantoprazole Sodium","TABLET, DELAYED RELEASE;ORAL","020987","WYETH PHARMS","04/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020987s053,022020s015lbl.pdf#page=30"
"Protonix","Pantoprazole Sodium","TABLET, DELAYED RELEASE;ORAL","020987","WYETH PHARMS","04/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020987s055,022020s017lbl.pdf#page=33"
"Protopic","Tacrolimus","OINTMENT;TOPICAL","050777","LEO PHARMA AS","02/25/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf"
"Provigil","Modafinil","TABLET;ORAL","020717","CEPHALON","01/15/2015","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf"
"Prozac","Fluoxetine Hydrochloride","CAPSULE;ORAL","018936","ELI LILLY AND CO","04/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018936s109lbl.pdf#page=26"
"Prozac","Fluoxetine Hydrochloride","CAPSULE;ORAL","018936","ELI LILLY AND CO","04/28/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"
"Prozac Weekly","Fluoxetine Hydrochloride","CAPSULE, DELAYED REL PELLETS;ORAL","021235","LILLY","03/24/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"
"Qmiiz ODT","Meloxicam","TABLET, ORALLY DISINTEGRATING;ORAL","211210","TERSERA THERAPS LLC","08/20/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211210s000lbl.pdf#page=35"
"Qsymia","Phentermine Hydrochloride; Topiramate","CAPSULE, EXTENDED RELEASE;ORAL","022580","VIVUS","03/23/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022580s016lbl.pdf#page=37"
"Qtern","Dapagliflozin; Saxagliptin Hydrochloride","TABLET;ORAL","209091","ASTRAZENECA AB","01/24/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209091s003lbl.pdf#page=37"
"Qtern","Dapagliflozin; Saxagliptin Hydrochloride","TABLET;ORAL","209091","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209091s000lbl.pdf"
"Qtern","Dapagliflozin; Saxagliptin Hydrochloride","TABLET;ORAL","209091","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209091s004lbl.pdf#page=40"
"Qtern","Dapagliflozin; Saxagliptin Hydrochloride","TABLET;ORAL","209091","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209091s005lbl.pdf#page=37"
"Qtern","Dapagliflozin; Saxagliptin Hydrochloride","TABLET;ORAL","209091","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209091s002lbl.pdf#page=40"
"Qternmet XR","Dapagliflozin; METformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","210874","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s000lbl.pdf#page=50"
"Qternmet XR","Dapagliflozin; METformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","210874","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47"
"Qternmet XR","Dapagliflozin; METformin Hydrochloride; Saxagliptin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","210874","ASTRAZENECA AB","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s001lbl.pdf#page=50"
"Qualaquin","Quinine Sulfate","CAPSULE;ORAL","021799","SUN PHARM INDUSTRIES","06/19/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM192698.pdf"
"Qualaquin","Quinine Sulfate","CAPSULE;ORAL","021799","SUN PHARM INDUSTRIES","06/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26"
"Qudexy XR","Topiramate","CAPSULE, EXTENDED RELEASE;ORAL","205122","UPSHER SMITH LABS","02/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205122s010lbl.pdf#page=60"
"Qudexy XR","Topiramate","CAPSULE, EXTENDED RELEASE;ORAL","205122","UPSHER SMITH LABS","02/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205122s003s005lbl.pdf#page=69"
"Qudexy XR","Topiramate","CAPSULE, EXTENDED RELEASE;ORAL","205122","UPSHER SMITH LABS","02/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205122s008lbl.pdf#page=59"
"Quillichew ER","Methylphenidate Hydrochloride","TABLET, EXTENDED RELEASE, CHEWABLE;ORAL","207960","NEXTWAVE PHARMS","02/28/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207960s005lbl.pdf#page=13"
"Quillivant XR","Methylphenidate Hydrochloride","FOR SUSPENSION, EXTENDED RELEASE;ORAL","202100","NEXTWAVE","01/24/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202100s012lbl.pdf#page=14"
"Rapamune","Sirolimus","SOLUTION;ORAL","021083","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021083s062,021110s081lbl.pdf#page=41"
"Rapamune","Sirolimus","TABLET;ORAL","021110","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021083s065,021110s084lbl.pdf#page=41"
"Rapamune","Sirolimus","SOLUTION;ORAL","021083","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021083s064,021110s083lbl.pdf#page=43"
"Rapamune","Sirolimus","TABLET;ORAL","021110","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021083s061,021110s080lbl.pdf#page=41"
"Rapamune","Sirolimus","SOLUTION;ORAL","021083","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021083s065,021110s084lbl.pdf#page=41"
"Rapamune","Sirolimus","TABLET;ORAL","021110","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021083s064,021110s083lbl.pdf#page=43"
"Rapamune","Sirolimus","SOLUTION;ORAL","021083","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43"
"Rapamune","Sirolimus","TABLET;ORAL","021110","PF PRISM CV","01/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43"
"Ravicti","Glycerol Phenylbutyrate","LIQUID;ORAL","203284","HORIZON THERAP","10/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203284s005lbl.pdf#page=1"
"Ravicti","Glycerol Phenylbutyrate","LIQUID;ORAL","203284","HORIZON THERAP","10/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203284s011lbl.pdf#page=27"
"Ravicti","Glycerol Phenylbutyrate","LIQUID;ORAL","203284","HORIZON THERAP","10/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203284s010lbl.pdf#page=27"
"Rebetol","Ribavirin","CAPSULE;ORAL","020903","MERCK SHARP DOHME","01/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020903s056,021546s012lbl.pdf#page=26"
"Rebetol","Ribavirin","SOLUTION;ORAL","021546","SCHERING","01/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020903s056,021546s012lbl.pdf#page=26"
"Rebif","Interferon Beta-1a","SYRINGE","103780","SERONO INC","05/26/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089019.pdf"
"Rebif","Interferon Beta-1a","SYRINGE","103780","SERONO INC","05/26/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103780s5203s5207lbl.pdf#page=16"
"Reclast","Zoledronic Acid","INJECTABLE;INTRAVENOUS","021817","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021817s027lbl.pdf#page=25"
"Reclast","Zoledronic Acid","INJECTABLE;INTRAVENOUS","021817","NOVARTIS","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25"
"Reglan","Metoclopramide Hydrochloride","TABLET;ORAL","017854","ANI PHARMS","08/29/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf"
"Reglan","Metoclopramide Hydrochloride","INJECTABLE;INJECTION","017862","WEST-WARD PHARMS INT","11/18/2010","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf"
"Reglan ODT","Metoclopramide Hydrochloride","TABLET, ORALLY DISINTEGRATING;ORAL","021793","MEDA PHARMS","11/30/2011","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf"
"Regranex","Becaplermin","GEL; TOPICAL","103691","SMITH AND NEPHEW","08/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8"
"Regranex","Becaplermin","GEL; TOPICAL","103691","SMITH AND NEPHEW","08/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103691s5134lbl.pdf#page=11"
"Relistor","Methylnaltrexone Bromide","TABLET;ORAL","208271","SALIX","03/14/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021964s018,208271s002lbl.pdf#page=29"
"Relistor","Methylnaltrexone Bromide","SOLUTION;SUBCUTANEOUS","021964","SALIX PHARMS","03/14/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021964s018,208271s002lbl.pdf#page=29"
"Remeron","Mirtazapine","TABLET;ORAL","020415","ORGANON USA INC","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020415s034s036,021208s024s026lbl.pdf#page=23"
"Remeron","Mirtazapine","TABLET;ORAL","020415","ORGANON USA INC","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020415s035lbl.pdf#page=24"
"Remeron","Mirtazapine","TABLET;ORAL","020415","ORGANON USA INC","04/29/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020415s026mg.pdf"
"Remeron Soltab","Mirtazapine","TABLET, ORALLY DISINTEGRATING;ORAL","021208","ORGANON USA INC","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020415s034s036,021208s024s026lbl.pdf#page=23"
"Remeron Soltab","Mirtazapine","TABLET, ORALLY DISINTEGRATING;ORAL","021208","ORGANON USA INC","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020415s035lbl.pdf#page=24"
"Remeron Soltab","Mirtazapine","TABLET, ORALLY DISINTEGRATING;ORAL","021208","ORGANON USA INC","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021208s025lbl.pdf#page=24"
"Remicade","Infliximab","VIAL","103772","CENTOCOR INC","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103772s5389s5391s5394lbl.pdf#page=50"
"Remicade","Infliximab","VIAL","103772","CENTOCOR INC","05/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103772s5385lbl.pdf#page=48"
"Renflexis","Infliximab-Abda","INJECTABLE;INJECTION","761054","SAMSUNG BIOEPIS CO LTD","06/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761054s004lbl.pdf#page=52"
"Renflexis","Infliximab-Abda","INJECTABLE;INJECTION","761054","SAMSUNG BIOEPIS CO LTD","06/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf#page=51"
"Renflexis","Infliximab-Abda","INJECTABLE;INJECTION","761054","SAMSUNG BIOEPIS CO LTD","06/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761054s009lbl.pdf#page=52"
"Restoril","Temazepam","CAPSULE;ORAL","018163","SPECGX LLC","02/06/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018163s064lbl.pdf#page=13"
"Restoril","Temazepam","CAPSULE;ORAL","018163","SPECGX LLC","02/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018163s065lbl.pdf#page=13"
"Retacrit","Epoetin Alfa-Epbx","INJECTABLE;INJECTION","125545","HOSPIRA INC","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31"
"Retacrit","Epoetin Alfa-Epbx","INJECTABLE;INJECTION","125545","HOSPIRA INC","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125545s003lbl.pdf#page=28"
"Retacrit","Epoetin Alfa-Epbx","INJECTABLE;INJECTION","125545","HOSPIRA INC","06/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125545s000lbl.pdf#page=28"
"Revlimid","Lenalidomide","CAPSULE;ORAL","021880","CELGENE","10/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s056lbl.pdf#page=42"
"Revlimid","Lenalidomide","CAPSULE;ORAL","021880","CELGENE","10/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s060lbl.pdf#page=49"
"Revlimid","Lenalidomide","CAPSULE;ORAL","021880","CELGENE","10/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021880s055lbl.pdf#page=42"
"Revlimid","Lenalidomide","CAPSULE;ORAL","021880","CELGENE","10/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s057lbl.pdf#page=49"
"Rexulti","Brexpiprazole","TABLET;ORAL","205422","OTSUKA PHARM CO LTD","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205422s005lbl.pdf#page=27"
"Rexulti","Brexpiprazole","TABLET;ORAL","205422","OTSUKA PHARM CO LTD","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422Orig1Orig2s000lbl.pdf#page=36"
"Reyvow","Lasmiditan Succinate","TABLET;ORAL","211280","ELI LILLY AND CO","07/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211280s001lbl.pdf#page=14"
"Rezira","Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride","SOLUTION;ORAL","022442","PERSION","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26"
"Ribasphere","Ribavirin","CAPSULE;ORAL","076203","KADMON PHARMS LLC","05/31/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111342.pdf"
"Rinvoq","Upadacitinib","TABLET, EXTENDED RELEASE;ORAL","211675","ABBVIE INC","07/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211675s001lbl.pdf#page=29"
"Rinvoq","Upadacitinib","TABLET, EXTENDED RELEASE;ORAL","211675","ABBVIE INC","07/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf#page=28"
"Ritalin","Methylphenidate Hydrochloride","TABLET;ORAL","010187","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s071s082,018029s041s051lbl.pdf#page=14"
"Ritalin","Methylphenidate Hydrochloride","TABLET;ORAL","010187","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13"
"Ritalin","Methylphenidate Hydrochloride","TABLET;ORAL","010187","NOVARTIS","11/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010187s087lbl.pdf#page=11"
"Ritalin LA","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021284","NOVARTIS","11/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021284s034lbl.pdf#page=18"
"Ritalin LA","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021284","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021284s016s029lbl.pdf#page=17"
"Ritalin LA","Methylphenidate Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","021284","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021284s041lbl.pdf#page=16"
"Ritalin-SR","Methylphenidate Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","018029","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s071s082,018029s041s051lbl.pdf#page=14"
"Ritalin-SR","Methylphenidate Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","018029","NOVARTIS","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13"
"Ritalin-SR","Methylphenidate Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","018029","NOVARTIS","11/19/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018029s055lbl.pdf#page=14"
"Rituxan","Rituximab","SOLUTION;INTRAVENOUS","103705","GENENTECH","03/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103705s5457lbl.pdf#page=46"
"Rituxan Hycela","Rituximab; Hyaluronidase (Human Recombinant)","SOLUTION;SUBCUTANEOUS","761064","GENENTECH INC","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761064s000lbl.pdf#page=29"
"Rituxan Hycela","Rituximab; Hyaluronidase (Human Recombinant)","SOLUTION;SUBCUTANEOUS","761064","GENENTECH INC","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761064s008s010lbl.pdf#page=28"
"Rituxan Hycela","Rituximab; Hyaluronidase (Human Recombinant)","SOLUTION;SUBCUTANEOUS","761064","GENENTECH INC","05/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761064s009lbl.pdf#page=26"
"Roxicodone","Oxycodone Hydrochloride","TABLET;ORAL","021011","SPECGX LLC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021011s010lbl.pdf#page=28"
"Roxybond","Oxycodone Hydrochloride","TABLET;ORAL","209777","OHEMO LIFE","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209777lbl.pdf#page=43"
"Roxybond","Oxycodone Hydrochloride","TABLET;ORAL","209777","OHEMO LIFE","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209777s006lbl.pdf#page=36"
"Rozerem","Ramelteon","TABLET;ORAL","021782","TAKEDA PHARMS USA","12/21/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021782s011Medguide.pdf"
"Rozerem","Ramelteon","TABLET;ORAL","021782","TAKEDA PHARMS USA","12/21/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021782s021lbl.pdf#page=16"
"Ruxience","Rituximab-Pvvr","INJECTABLE;INJECTION","761103","PFIZER INC","05/26/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761103s000lbl.pdf#page=31"
"Ruxience","Rituximab-Pvvr","INJECTABLE;INJECTION","761103","PFIZER INC","05/26/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761103s003lbl.pdf#page=32"
"Ruzurgi","Amifampridine","TABLET;ORAL","209321","JACOBUS PHARM CO INC","08/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15"
"Rybelsus","Semaglutide","TABLET;ORAL","213051","NOVO","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23"
"Rybelsus","Semaglutide","TABLET;ORAL","213182","NOVO NORDISK INC","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23"
"Rybelsus","Semaglutide","TABLET;ORAL","213051","NOVO","01/16/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf#page=24"
"Sabril","Vigabatrin","TABLET;ORAL","020427","LUNDBECK PHARMS LLC","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022006s020,020427s018lbl.pdf#page=26"
"Sabril","Vigabatrin","TABLET;ORAL","020427","LUNDBECK PHARMS LLC","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020427s020,022006s022lbl.pdf#page=26"
"Sabril","Vigabatrin","FOR SOLUTION;ORAL","022006","LUNDBECK PHARMS LLC","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020427s020,022006s022lbl.pdf#page=26"
"Sabril","Vigabatrin","FOR SOLUTION;ORAL","022006","LUNDBECK PHARMS LLC","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022006s020,020427s018lbl.pdf#page=26"
"Samsca","Tolvaptan","TABLET;ORAL","022275","OTSUKA AMERICA PHARM","04/23/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022275s016lbl.pdf#page=24"
"Sarafem","Fluoxetine Hydrochloride","CAPSULE;ORAL","018936","ELI LILLY AND CO","04/28/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018936s109lbl.pdf#page=26"
"Sarafem","Fluoxetine Hydrochloride","TABLET;ORAL","021860","APIL","01/04/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021860s011lbl.pdf#page=33"
"Sarafem","Fluoxetine Hydrochloride","TABLET;ORAL","021860","APIL","01/04/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089119.pdf"
"Sarafem","Fluoxetine Hydrochloride","CAPSULE;ORAL","018936","ELI LILLY AND CO","04/28/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28"
"Savaysa","Edoxaban Tosylate","TABLET;ORAL","206316","DAIICHI SANKYO INC","04/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206316s015lbl.pdf#page=34"
"Savaysa","Edoxaban Tosylate","TABLET;ORAL","206316","DAIICHI SANKYO INC","04/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206316s016lbl.pdf#page=35"
"Savaysa","Edoxaban Tosylate","TABLET;ORAL","206316","DAIICHI SANKYO INC","04/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206316s012lbl.pdf#page=32"
"Savella","Milnacipran Hydrochloride","TABLET;ORAL","022256","ALLERGAN","12/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022256s023lbl.pdf#page=30"
"Saxenda","Liraglutide Recombinant","SOLUTION;SUBCUTANEOUS","206321","NOVO","03/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206321s004s006lbl.pdf#page=26"
"Saxenda","Liraglutide Recombinant","SOLUTION;SUBCUTANEOUS","206321","NOVO","03/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206321s011lbl.pdf#page=26"
"Segluromet","Ertugliflozin; METformin Hydrochloride","TABLET;ORAL","209806","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209806s001lbl.pdf#page=32"
"Segluromet","Ertugliflozin; METformin Hydrochloride","TABLET;ORAL","209806","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209806s002lbl.pdf#page=32"
"Selzentry","Maraviroc","TABLET;ORAL","022128","VIIV HLTHCARE","07/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022128s018,208984s001lbl.pdf#page=43"
"Selzentry","Maraviroc","SOLUTION;ORAL","208984","VIIV HLTHCARE","07/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022128s018,208984s001lbl.pdf#page=43"
"Serevent","Salmeterol Xinafoate","POWDER;INHALATION","020692","GLAXOSMITHKLINE","07/22/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020692s038MedG.pdf"
"Serevent","Salmeterol Xinafoate","POWDER;INHALATION","020692","GLAXOSMITHKLINE","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020692s046lbl.pdf#page=34"
"Serevent","Salmeterol Xinafoate","POWDER;INHALATION","020692","GLAXOSMITHKLINE","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35"
"Seroquel","Quetiapine Fumarate","TABLET;ORAL","020639","ASTRAZENECA PHARMS","03/27/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089126.pdf"
"Seroquel","Quetiapine Fumarate","TABLET;ORAL","020639","ASTRAZENECA PHARMS","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020639s069lbl.pdf#page=49"
"Seroquel","Quetiapine Fumarate","TABLET;ORAL","020639","ASTRAZENECA PHARMS","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020639s060s063lbl.pdf#page=48"
"Seroquel","Quetiapine Fumarate","TABLET;ORAL","020639","ASTRAZENECA PHARMS","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020639s066lbl.pdf#page=49"
"Seroquel XR","Quetiapine Fumarate","TABLET, EXTENDED RELEASE;ORAL","022047","ASTRAZENECA","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022047s033s037lbl.pdf#page=52"
"Seroquel XR","Quetiapine Fumarate","TABLET, EXTENDED RELEASE;ORAL","022047","ASTRAZENECA","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022047s040lbl.pdf#page=52"
"Seroquel XR","Quetiapine Fumarate","TABLET, EXTENDED RELEASE;ORAL","022047","ASTRAZENECA","03/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022047Orig1s042lbl.pdf#page=52"
"Signifor","Pasireotide Diaspartate","SOLUTION;SUBCUTANEOUS","200677","RECORDATI RARE","01/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15"
"Signifor","Pasireotide Diaspartate","SOLUTION;SUBCUTANEOUS","200677","RECORDATI RARE","01/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200677s005lbl.pdf#page=16"
"Signifor","Pasireotide Diaspartate","SOLUTION;SUBCUTANEOUS","200677","RECORDATI RARE","01/15/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM332633.pdf"
"Signifor LAr Kit","Pasireotide Pamoate","FOR SUSPENSION;INTRAMUSCULAR","203255","RECORDATI RARE","07/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203255s004lbl.pdf#page=27"
"Siklos","Hydroxyurea","TABLET;ORAL","208843","ADDMEDICA SAS","05/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208843s000lbl.pdf#page=17"
"Siklos","Hydroxyurea","TABLET;ORAL","208843","ADDMEDICA SAS","05/22/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208843s002lbl.pdf#page=17"
"Silenor","Doxepin Hydrochloride","TABLET;ORAL","022036","CURRAX","12/22/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM206668.pdf"
"Siliq","Brodalumab","INJECTABLE;INJECTION","761032","VALEANT LUXEMBOURG","10/09/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf#page=13"
"Simponi","Golimumab","INJECTABLE; INJECTION","125289","CENTOCOR ORTHO BIOTECH INC","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38"
"Simponi Aria","Golimumab","INJECTABLE; INJECTION","125433","JANSSEN BIOTECH","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125433s028lbl.pdf#page=31"
"Simponi Aria","Golimumab","INJECTABLE; INJECTION","125433","JANSSEN BIOTECH","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125433s024lbl.pdf#page=28"
"Sinequan","Doxepin Hydrochloride","CAPSULE;ORAL","016798","PFIZER","07/14/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf"
"Singulair","Montelukast Sodium","TABLET, CHEWABLE;ORAL","020830","MSD MERCK CO","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020829s073,020830s075,021409s051lbl.pdf#page=22"
"Singulair","Montelukast Sodium","TABLET;ORAL","020829","MSD MERCK CO","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020829s073,020830s075,021409s051lbl.pdf#page=22"
"Singulair","Montelukast Sodium","GRANULE;ORAL","021409","MERCK","04/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020829s073,020830s075,021409s051lbl.pdf#page=22"
"Sirturo","Bedaquiline Fumarate","TABLET;ORAL","204384","JANSSEN THERAP","05/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204384s011lbl.pdf#page=24"
"Sirturo","Bedaquiline Fumarate","TABLET;ORAL","204384","JANSSEN THERAP","05/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204384s014lbl.pdf#page=24"
"Skyrizi","Risankizumab-Rzaa","INJECTABLE;INJECTION","761105","ABBVIE INC","03/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761105s005lbl.pdf#page=13"
"Skyrizi","Risankizumab-Rzaa","INJECTABLE;INJECTION","761105","ABBVIE INC","03/20/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761105s000lbl.pdf#page=12"
"Sodium Oxybate","Sodium Oxybate","SOLUTION;ORAL","202090","HIKMA","01/17/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18"
"Solaraze","Diclofenac Sodium","GEL;TOPICAL","021005","FOUGERA PHARMS","05/16/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf"
"Soliqua 100/33","Insulin Glargine; Lixisenatide","SOLUTION;SUBCUTANEOUS","208673","SANOFI-AVENTIS US","11/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208673s008s009lbl.pdf#page=30"
"Soliris","Eculizumab","INJECTABLE; IV (INFUSION)","125166","ALEXION PHARM","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40"
"Soliris","Eculizumab","INJECTABLE; IV (INFUSION)","125166","ALEXION PHARM","04/07/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125166Orig1s427s428MedGuide.pdf"
"Soltamox","Tamoxifen Citrate","SOLUTION;ORAL","021807","FORTOVIA","04/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36"
"Soltamox","Tamoxifen Citrate","SOLUTION;ORAL","021807","FORTOVIA","04/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021807s005lbl.pdf#page=36"
"Soltamox","Tamoxifen Citrate","SOLUTION;ORAL","021807","FORTOVIA","04/08/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021807lblMG.pdf"
"Sonata","Zaleplon","CAPSULE;ORAL","020859","PFIZER","08/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM349707.pdf"
"Sonata","Zaleplon","CAPSULE;ORAL","020859","PFIZER","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s015lbl.pdf#page=21"
"Sonata","Zaleplon","CAPSULE;ORAL","020859","PFIZER","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21"
"Soriatane","Acitretin","CAPSULE;ORAL","019821","STIEFEL LABS INC","09/27/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019821s018mg.pdf"
"Sotret","Isotretinoin","CAPSULE;ORAL","076041","SUN PHARM INDS LTD","04/12/2012","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf"
"Spravato","Esketamine Hydrochloride","SPRAY;NASAL","211243","JANSSEN PHARMS","07/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211243s004lbl.pdf#page=42"
"Spritam","Levetiracetam","TABLET, FOR SUSPENSION;ORAL","207958","APRECIA PHARMS","09/12/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207958s004lbl.pdf#page=36"
"Spritam","Levetiracetam","TABLET, FOR SUSPENSION;ORAL","207958","APRECIA PHARMS","09/12/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207958s008lbl.pdf#page=34"
"Sprix","Ketorolac Tromethamine","SPRAY, METERED;NASAL","022382","ZYLA","01/22/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022382s018lbl.pdf#page=20"
"Steglatro","Ertugliflozin","TABLET;ORAL","209803","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209803s000lbl.pdf#page=24"
"Steglatro","Ertugliflozin","TABLET;ORAL","209803","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209803s002lbl.pdf#page=25"
"Steglatro","Ertugliflozin","TABLET;ORAL","209803","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209803s001lbl.pdf#page=25"
"Steglujan","Ertugliflozin; Sitagliptin Phosphate","TABLET;ORAL","209805","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209805s006lbl.pdf#page=32"
"Steglujan","Ertugliflozin; Sitagliptin Phosphate","TABLET;ORAL","209805","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209805s004lbl.pdf#page=32"
"Steglujan","Ertugliflozin; Sitagliptin Phosphate","TABLET;ORAL","209805","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209805s005lbl.pdf#page=32"
"Steglujan","Ertugliflozin; Sitagliptin Phosphate","TABLET;ORAL","209805","MERCK SHARP DOHME","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209805s001lbl.pdf#page=32"
"Stelara","Ustekinumab","INJECTABLE;INJECTION","761044","JANSSEN BIOTECH","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125261Orig1s153,761044s005lbl.pdf#page=39"
"Stelara","Ustekinumab","INJECTABLE; INJECTION","125261","CENTOCOR ORTHO BIOTECH INC","07/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125261s147lbl.pdf#page=30"
"Stelara","Ustekinumab","INJECTABLE; INJECTION","125261","CENTOCOR ORTHO BIOTECH INC","07/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125261s142,761044s001lbl.pdf#page=36"
"Stelara","Ustekinumab","INJECTABLE; INJECTION","125261","CENTOCOR ORTHO BIOTECH INC","07/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125261s150lbl.pdf#page=36"
"Stelara","Ustekinumab","INJECTABLE;INJECTION","761044","JANSSEN BIOTECH","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125261s142,761044s001lbl.pdf#page=36"
"Stelara","Ustekinumab","INJECTABLE;INJECTION","761044","JANSSEN BIOTECH","04/07/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761044s003lbl.pdf#page=35"
"Strattera","Atomoxetine Hydrochloride","CAPSULE;ORAL","021411","LILLY","02/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021411s048lbl.pdf#page=19"
"Strattera","Atomoxetine Hydrochloride","CAPSULE;ORAL","021411","LILLY","02/25/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021411s049lbl.pdf#page=21"
"Striverdi Respimat","Olodaterol Hydrochloride","SPRAY, METERED;INHALATION","203108","BOEHRINGER INGELHEIM","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf"
"Sublocade","Buprenorphine","SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS","209819","INDIVIOR INC","06/15/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209819s012lbl.pdf#page=41"
"Suboxone","Buprenorphine Hydrochloride; Naloxone Hydrochloride","FILM;BUCCAL, SUBLINGUAL","022410","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022410s038lbl.pdf#page=32"
"Suboxone","Buprenorphine Hydrochloride; Naloxone Hydrochloride","FILM;BUCCAL, SUBLINGUAL","022410","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022410s033,020732s019,020733s023lbl.pdf#page=32"
"Suboxone","Buprenorphine Hydrochloride; Naloxone Hydrochloride","TABLET;SUBLINGUAL","020733","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020733s024lbl.pdf#page=30"
"Subsys","Fentanyl","SPRAY;SUBLINGUAL","202788","BTCP PHARMA","10/07/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202788s016lbl.pdf#page=38"
"Subsys","Fentanyl","SPRAY;SUBLINGUAL","202788","BTCP PHARMA","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202788s020lbl.pdf#page=38"
"Subutex","Buprenorphine Hydrochloride","TABLET;SUBLINGUAL","020732","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020732s020lbl.pdf#page=27"
"Subutex","Buprenorphine Hydrochloride","TABLET;SUBLINGUAL","020732","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020732s022lbl.pdf#page=27"
"Subutex","Buprenorphine Hydrochloride","TABLET;SUBLINGUAL","020732","INDIVIOR INC","03/02/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022410s033,020732s019,020733s023lbl.pdf#page=32"
"Suclear","Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Potassium Sulfate; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate","SOLUTION;ORAL","203595","BRAINTREE LABS","08/15/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337734.pdf"
"Sunosi","Solriamfetol Hydrochloride","TABLET;ORAL","211230","JAZZ","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211230_Orig1Orig2s000lbl.pdf#page=23"
"Supprelin LA","Histrelin Acetate","IMPLANT;SUBCUTANEOUS","022058","ENDO PHARM","11/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022058s014s015lbl.pdf#page=19"
"Supprelin LA","Histrelin Acetate","IMPLANT;SUBCUTANEOUS","022058","ENDO PHARM","11/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022058s016lbl.pdf#page=20"
"Suprep Bowel Prep Kit","Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate","SOLUTION;ORAL","022372","BRAINTREE LABS","08/05/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022372s000MedGuide.pdf"
"Suprep Bowel Prep Kit","Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate","SOLUTION;ORAL","022372","BRAINTREE LABS","08/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13"
"Surmontil","Trimipramine Maleate","CAPSULE;ORAL","016792","ODYSSEY PHARMS","09/30/2014","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12"
"Sustol","Granisetron","INJECTION, EXTENDED RELEASE;SUBCUTANEOUS","022445","HERON THERAPS INC","08/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM524796.pdf"
"Sutent","Sunitinib Malate","CAPSULE;ORAL","021938","CPPI CV","08/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021938s037lbl.pdf#page=33"
"Sutent","Sunitinib Malate","CAPSULE;ORAL","021938","CPPI CV","08/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021938s038lbl.pdf#page=35"
"Sutent","Sunitinib Malate","CAPSULE;ORAL","021938","CPPI CV","08/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021938s036lbl.pdf#page=35"
"Sutent","Sunitinib Malate","CAPSULE;ORAL","021938","CPPI CV","08/14/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM219111.pdf"
"Sylatron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5311lbl.pdf#page=27"
"Sylatron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13"
"Sylatron","Peginterferon Alfa-2b","VIAL","103949","SCHERING","01/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29"
"Symbyax","Fluoxetine Hydrochloride; Olanzapine","CAPSULE;ORAL","021520","LILLY","04/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021520s050lbl.pdf#page=42"
"Symbyax","Fluoxetine Hydrochloride; Olanzapine","CAPSULE;ORAL","021520","LILLY","04/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021520s053lbl.pdf#page=42"
"Symlin","Pramlintide Acetate","INJECTABLE;SUBCUTANEOUS","021332","ASTRAZENECA AB","12/18/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf"
"Sympazan","Clobazam","FILM;ORAL","210833","AQUESTIVE THERAP","11/01/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210833s000lbl.pdf#page=26"
"Symproic","Naldemedine Tosylate","TABLET;ORAL","208854","BDSI","01/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13"
"Synalgos-DC","Aspirin; Caffeine; Dihydrocodeine Bitartrate","CAPSULE;ORAL","011483","SUN PHARM INDUSTRIES","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011483s033lbl.pdf#page=28"
"Synarel","Nafarelin Acetate","SPRAY, METERED;NASAL","019886","PFIZER","05/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf#page=28"
"Synjardy","Empagliflozin; METformin Hydrochloride","TABLET;ORAL","206111","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206111s018lbl.pdf#page=39"
"Synjardy","Empagliflozin; METformin Hydrochloride","TABLET;ORAL","206111","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206111s015lbl.pdf#page=39"
"Synjardy XR","Empagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","208658","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206111s018lbl.pdf#page=39"
"Synjardy XR","Empagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","208658","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208658s009lbl.pdf#page=39"
"Synjardy XR","Empagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","208658","BOEHRINGER INGELHEIM","01/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208658s004lbl.pdf#page=39"
"Synribo","Omacetaxine Mepesuccinate","POWDER;SUBCUTANEOUS","203585","TEVA PHARMS INTL","11/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203585s007lbl.pdf#page=16"
"Tafinlar","Dabrafenib Mesylate","CAPSULE;ORAL","202806","NOVARTIS","04/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202806s015lbl.pdf#page=34"
"Tafinlar","Dabrafenib Mesylate","CAPSULE;ORAL","202806","NOVARTIS","04/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202806s012lbl.pdf#page=35"
"Taltz","Ixekizumab","INJECTABLE;INJECTION","125521","ELI LILLY AND CO","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s020lbl.pdf#page=17"
"Taltz","Ixekizumab","INJECTABLE;INJECTION","125521","ELI LILLY AND CO","05/29/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM493178.pdf"
"Taltz","Ixekizumab","INJECTABLE;INJECTION","125521","ELI LILLY AND CO","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s019lbl.pdf#page=19"
"Tanzeum","Albiglutide","INJECTABLE;INJECTION","125431","GLAXOSMITHKLINE LLC","12/20/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36"
"Targiniq","Naloxone Hydrochloride; Oxycodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205777","PURDUE PHARMA LP","09/18/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205777s004lbl.pdf#page=46"
"Targiniq","Naloxone Hydrochloride; Oxycodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205777","PURDUE PHARMA LP","09/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47"
"Tasigna","Nilotinib Hydrochloride","CAPSULE;ORAL","022068","NOVARTIS","09/25/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022068s031lbl.pdf#page=36"
"Tazverik","Tazemetostat Hydrobromide","TABLET;ORAL","211723","EPIZYME INC","01/23/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf#page=14"
"Tazverik","Tazemetostat Hydrobromide","TABLET;ORAL","213400","EPIZYME INC","06/18/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17"
"Tecentriq","Atezolizumab","INJECTABLE; INJECTION","761041","GENENTECH INC","10/18/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm530718.pdf"
"Tecentriq","Atezolizumab","INJECTABLE;INJECTION","761034","GENENTECH INC","07/30/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761034s021lbl.pdf#page=47"
"Tecentriq","Atezolizumab","INJECTABLE;INJECTION","761034","GENENTECH INC","07/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761034s025lbl.pdf#page=55"
"Technivie","Ombitasvir; Paritaprevir; Ritonavir","TABLET;ORAL","207931","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39"
"Technivie","Ombitasvir; Paritaprevir; Ritonavir","TABLET;ORAL","207931","ABBVIE INC","12/06/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207931s012lbl.pdf#page=38"
"Tegretol","Carbamazepine","TABLET;ORAL","016608","NOVARTIS","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"
"Tegretol","Carbamazepine","TABLET, CHEWABLE;ORAL","018281","NOVARTIS","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"
"Tegretol","Carbamazepine","SUSPENSION;ORAL","018927","NOVARTIS","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"
"Tegretol-XR","Carbamazepine","TABLET, EXTENDED RELEASE;ORAL","020234","NOVARTIS","03/20/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19"
"Tegsedi","Inotersen Sodium","SOLUTION;SUBCUTANEOUS","211172","AKCEA THERAPS","07/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211172s008lbl.pdf#page=26"
"Tegsedi","Inotersen Sodium","SOLUTION;SUBCUTANEOUS","211172","AKCEA THERAPS","07/30/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211172lbl.pdf#page=41"
"Testim","Testosterone","GEL;TRANSDERMAL","021454","AUXILIUM PHARMS LLC","05/30/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM188475.pdf"
"Testim","Testosterone","GEL;TRANSDERMAL","021454","AUXILIUM PHARMS LLC","05/30/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021454s027lbl.pdf#page=21"
"Testosterone","Testosterone","GEL;TRANSDERMAL","202763","ANI PHARMS INC","10/25/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf"
"Thalomid","Thalidomide","CAPSULE;ORAL","020785","CELGENE","12/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s065lbl.pdf#page=25"
"Thalomid","Thalidomide","CAPSULE;ORAL","020785","CELGENE","12/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020785s067lbl.pdf#page=23"
"Thalomid","Thalidomide","CAPSULE;ORAL","020785","CELGENE","12/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020785s068lbl.pdf#page=23"
"Tibsovo","Ivosidenib","TABLET;ORAL","211192","AGIOS PHARMS INC","03/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211192s000lbl.pdf#page=18"
"Tikosyn","Dofetilide","CAPSULE;ORAL","020931","PFIZER","08/08/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM266314.pdf"
"Tikosyn","Dofetilide","CAPSULE;ORAL","020931","PFIZER","08/08/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27"
"Tivorbex","Indomethacin","CAPSULE;ORAL","204768","GENUS","03/26/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501662.pdf"
"Tivorbex","Indomethacin","CAPSULE;ORAL","204768","GENUS","03/26/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204768s006lbl.pdf#page=23"
"Tofranil","Imipramine Hydrochloride","TABLET;ORAL","087846","SPECGX LLC","06/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3"
"Tofranil-Pm","Imipramine Pamoate","CAPSULE;ORAL","017090","SPECGX LLC","07/28/2014","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf"
"Tolectin","Tolmetin Sodium","TABLET;ORAL","017628","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"Tolectin 600","Tolmetin Sodium","TABLET;ORAL","017628","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"Tolectin DS","Tolmetin Sodium","CAPSULE;ORAL","018084","ORTHO MCNEIL JANSSEN","01/22/2008","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf"
"Topamax","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020505s59_020844s50lbl.pdf#page=51"
"Topamax","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020505s060,020844s051lbl.pdf#page=51"
"Topamax","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020505s061,020844s052lbl.pdf#page=52"
"Topamax","Topiramate","TABLET;ORAL","020505","JANSSEN PHARMS","06/08/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020505s059,020844s050lbl.pdf#page=51"
"Topamax","Topiramate","TABLET;ORAL","020505","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020505s060,020844s051lbl.pdf#page=51"
"Topamax","Topiramate","TABLET;ORAL","020505","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020505s061,020844s052lbl.pdf#page=52"
"Topamax Sprinkle","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020505s060,020844s051lbl.pdf#page=51"
"Topamax Sprinkle","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020505s59_020844s50lbl.pdf#page=51"
"Topamax Sprinkle","Topiramate","CAPSULE;ORAL","020844","JANSSEN PHARMS","06/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020505s061,020844s052lbl.pdf#page=52"
"Toradol","Ketorolac Tromethamine","TABLET;ORAL","019645","ROCHE PALO","03/26/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089165.pdf"
"Tracleer","Bosentan","TABLET, FOR SUSPENSION;ORAL","209279","ACTELION PHARMS","05/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
"Tracleer","Bosentan","TABLET;ORAL","021290","ACTELION PHARMS LTD","05/16/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30"
"Tradjenta","Linagliptin","TABLET;ORAL","201280","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201280s020lbl.pdf#page=17"
"Tradjenta","Linagliptin","TABLET;ORAL","201280","BOEHRINGER INGELHEIM","03/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201280s021lbl.pdf#page=14"
"Transderm Scop","Scopolamine","FILM, EXTENDED RELEASE;TRANSDERMAL","017874","GLAXOSMITHKLINE CON","03/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017874s043s044lbl.pdf#page=20"
"Tranxene","Clorazepate Dipotassium","CAPSULE;ORAL","017105","RECORDATI RARE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017105s079lbl.pdf#page=10"
"Tranxene","Clorazepate Dipotassium","TABLET;ORAL","017105","RECORDATI RARE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017105s079lbl.pdf#page=10"
"Tranxene SD","Clorazepate Dipotassium","TABLET;ORAL","017105","RECORDATI RARE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017105s079lbl.pdf#page=10"
"Trazodone Hydrochloride","Trazodone Hydrochloride","TABLET;ORAL","071196","APOTEX INC","04/20/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3"
"Trelegy Ellipta","Fluticasone Furoate; Umeclidinium Bromide; Vilanterol Trifenatate","POWDER;INHALATION","209482","GLAXOSMITHKLINE","05/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33"
"Tremfya","Guselkumab","INJECTABLE;INJECTION","761061","JANSSEN BIOTECH","07/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15"
"Tremfya","Guselkumab","INJECTABLE;INJECTION","761061","JANSSEN BIOTECH","07/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761061s004lbl.pdf#page=15"
"Treximet","Naproxen Sodium; Sumatriptan Succinate","TABLET;ORAL","021926","CURRAX","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021926s016lbl.pdf#page=29"
"Tridione","Trimethadione","SOLUTION;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"Tridione","Trimethadione","TABLET;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"Tridione","Trimethadione","CAPSULE;ORAL","005856","ABBVIE","06/07/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf"
"Trijardy XR","Empagliflozin; Linagliptin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","212614","BOEHRINGER INGELHEIM","01/27/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf#page=42"
"Trileptal","Oxcarbazepine","TABLET;ORAL","021014","NOVARTIS","01/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
"Trileptal","Oxcarbazepine","SUSPENSION;ORAL","021285","NOVARTIS","01/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26"
"Trintellix","Vortioxetine Hydrobromide","TABLET;ORAL","204447","TAKEDA PHARMS USA","07/23/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204447s018lbl.pdf#page=29"
"Triptodur Kit","Triptorelin Pamoate","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","208956","ARBOR PHARMS LLC","10/04/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208956s000lbl.pdf#page=12"
"Triumeq","Abacavir Sulfate; Dolutegravir Sodium; LAmivudine","TABLET;ORAL","205551","VIIV HLTHCARE","03/24/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205551s022lbl.pdf#page=44"
"Trizivir","Abacavir Sulfate; LAmivudine; Zidovudine","TABLET;ORAL","021205","VIIV HLTHCARE","05/10/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34"
"Trokendi XR","Topiramate","CAPSULE, EXTENDED RELEASE;ORAL","201635","SUPERNUS PHARMS","02/21/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201635s011s017lbl.pdf#page=58"
"Troxyca ER","Naltrexone Hydrochloride; Oxycodone Hydrochloride","CAPSULE, EXTENDED RELEASE;ORAL","207621","PFIZER","05/26/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32"
"Trulance","Plecanatide","TABLET;ORAL","208745","SALIX","07/25/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208745s001lbl.pdf#page=14"
"Trulicity","Dulaglutide","INJECTABLE;INJECTION","125469","ELI LILLY AND CO","02/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125469s023lbl.pdf#page=23"
"Trulicity","Dulaglutide","INJECTABLE;INJECTION","125469","ELI LILLY AND CO","02/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125469s033lbl.pdf#page=26"
"Truvada","Emtricitabine; Tenofovir Disoproxil Fumarate","TABLET;ORAL","021752","GILEAD","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021752s053lbl.pdf#page=42"
"Truvada","Emtricitabine; Tenofovir Disoproxil Fumarate","TABLET;ORAL","021752","GILEAD","06/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021752s061lbl.pdf#page=35"
"Truxima","Rituximab-Abbs","INJECTABLE;INJECTION","761088","CELLTRION INC","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761088s005s006lbl.pdf#page=48"
"Truxima","Rituximab-Abbs","INJECTABLE;INJECTION","761088","CELLTRION INC","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761088Orig1s001s002_Replacementlbl.pdf#page=30"
"Truxima","Rituximab-Abbs","INJECTABLE;INJECTION","761088","CELLTRION INC","05/29/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761088s009lbl.pdf#page=48"
"Turalio","Pexidartinib Hydrochloride","CAPSULE;ORAL","211810","DAIICHI SANKYO INC","08/04/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf#page=21"
"Turalio","Pexidartinib Hydrochloride","CAPSULE;ORAL","211810","DAIICHI SANKYO INC","08/04/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211810s003lbl.pdf#page=21"
"Tussionex Pennkinetic","Chlorpheniramine Polistirex; Hydrocodone Polistirex","SUSPENSION, EXTENDED RELEASE;ORAL","019111","UCB INC","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25"
"Tuxarin ER","Chlorpheniramine Maleate; Codeine Phosphate","TABLET, EXTENDED RELEASE;ORAL","206323","MAINPOINTE","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206323s006lbl.pdf#page=28"
"Tuzistra XR","Chlorpheniramine Polistirex; Codeine Polistirex","SUSPENSION, EXTENDED RELEASE;ORAL","207768","AYTU","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207768s007lbl.pdf#page=27"
"Tymlos","Abaloparatide","SOLUTION;SUBCUTANEOUS","208743","RADIUS HEALTH INC","10/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208743lbl.pdf#page=18"
"Tysabri","Natalizumab","VIAL; SINGLE-USE","125104","BIOGEN IDEC","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125104s966lbl.pdf#page=30"
"Tysabri","Natalizumab","VIAL; SINGLE-USE","125104","BIOGEN IDEC","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/1215104s959lbl.pdf#page=30"
"Tysabri","Natalizumab","VIAL; SINGLE-USE","125104","BIOGEN IDEC","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125104s968s969lbl.pdf#page=31"
"Tyzeka","Telbivudine","SOLUTION;ORAL","022154","NOVARTIS","12/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
"Tyzeka","Telbivudine","TABLET;ORAL","022011","NOVARTIS","12/27/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19"
"Uloric","Febuxostat","TABLET;ORAL","021856","TAKEDA PHARMS USA","02/21/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021856s013lbl.pdf#page=19"
"Ultomiris","Ravulizumab-Cwvz","INJECTABLE;INJECTION","761108","ALEXION PHARM","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761108s001lbl.pdf#page=29"
"Ultracet","Acetaminophen; Tramadol Hydrochloride","TABLET;ORAL","021123","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021123s019lbl.pdf#page=48"
"Ultram","Tramadol Hydrochloride","TABLET;ORAL","020281","JANSSEN PHARMS","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020281s045lbl.pdf#page=41"
"Ultram ER","Tramadol Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021692","VALEANT PHARMS","08/29/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36"
"Uplizna","Inebilizumab-Cdon","INJECTABLE;INJECTION","761142","VIELA BIO","06/11/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17"
"Valchlor","Mechlorethamine Hydrochloride","GEL;TOPICAL","202317","HELSINN","05/01/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10"
"Valchlor","Mechlorethamine Hydrochloride","GEL;TOPICAL","202317","HELSINN","05/01/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM366908.pdf"
"Valium","Diazepam","TABLET;ORAL","013263","ROCHE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013263s094lbl.pdf#page=14"
"Valtoco","Diazepam","SPRAY;NASAL","211635","NEURELIS INC","01/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211635s000lbl.pdf#page=23"
"Vantrela ER","Hydrocodone Bitartrate","TABLET, EXTENDED RELEASE;ORAL","207975","TEVA BRANDED PHARM","05/26/2017","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39"
"Venclexta","Venetoclax","TABLET;ORAL","208573","ABBVIE INC","06/12/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208573s018lbl.pdf#page=46"
"Venclexta","Venetoclax","TABLET;ORAL","208573","ABBVIE INC","06/12/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208573s011s014s015lbl.pdf#page=47"
"Venlafaxine Hydrochloride","Venlafaxine Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","022104","OSMOTICA PHARM","12/19/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022104s016lbl.pdf#page=35"
"Vibativ","Telavancin","INJECTABLE; INJECTION","022407","THERAVANCE INC","06/21/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"
"Vibativ","Telavancin Hydrochloride","POWDER;INTRAVENOUS","022110","CUMBERLAND PHARMS","07/07/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf"
"Viberzi","Eluxadoline","TABLET;ORAL","206940","ALLERGAN HOLDINGS","06/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20"
"Vicoprofen","Hydrocodone Bitartrate; Ibuprofen","TABLET;ORAL","020716","ABBVIE","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36"
"Victoza","Liraglutide Recombinant","SOLUTION;SUBCUTANEOUS","022341","NOVO NORDISK INC","08/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022341s031lbl.pdf#page=34"
"Victoza","Liraglutide Recombinant","SOLUTION;SUBCUTANEOUS","022341","NOVO NORDISK INC","08/05/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022341s035lbl.pdf#page=32"
"Victrelis","Boceprevir","CAPSULE;ORAL","202258","MERCK SHARP DOHME","01/30/2017","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM255471.pdf"
"Videx","Didanosine","FOR SOLUTION;ORAL","020156","BRISTOL-MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34"
"Videx","Didanosine","FOR SOLUTION;ORAL","020156","BRISTOL-MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s053lbl.pdf#page=32"
"Videx EC","Didanosine","CAPSULE, DELAYED REL PELLETS;ORAL","021183","BRISTOL MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33"
"Viekira Pak (Copackaged)","Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir","TABLET, TABLET;ORAL","206619","ABBVIE INC","12/06/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206619s018lbl.pdf#page=50"
"Viekira Pak (Copackaged)","Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir","TABLET, TABLET;ORAL","206619","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49"
"Viekira XR","Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir","TABLET, EXTENDED RELEASE;ORAL","208624","ABBVIE INC","12/06/2019","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208624s006lbl.pdf?page48"
"Viekira XR","Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir","TABLET, EXTENDED RELEASE;ORAL","208624","ABBVIE INC","12/06/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49"
"Viibryd","Vilazodone Hydrochloride","TABLET;ORAL","022567","ALLERGAN","01/31/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022567s020lbl.pdf#page=17"
"Viibryd","Vilazodone Hydrochloride","TABLET;ORAL","022567","ALLERGAN","01/31/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022567s021lbl.pdf#page=17"
"Vimovo","Esomeprazole Magnesium; Naproxen","TABLET, DELAYED RELEASE;ORAL","022511","HORIZON","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022511s023lbl.pdf#page=38"
"Vimovo","Esomeprazole Magnesium; Naproxen","TABLET, DELAYED RELEASE;ORAL","022511","HORIZON","07/22/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022511s024lbl.pdf#page=38"
"Vimpat","Lacosamide","SOLUTION;ORAL","022255","UCB INC","06/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022253s045,022254s035,022255s026lbl.pdf#page=26"
"Vimpat","Lacosamide","TABLET;ORAL","022253","UCB INC","06/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022253s045,022254s035,022255s026lbl.pdf#page=26"
"Vimpat","Lacosamide","SOLUTION;INTRAVENOUS","022254","UCB INC","06/11/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022253s045,022254s035,022255s026lbl.pdf#page=26"
"Viramune","Nevirapine","TABLET;ORAL","020636","BOEHRINGER INGELHEIM","09/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020636s050,020933s040lbl.pdf#page=19"
"Viramune","Nevirapine","SUSPENSION;ORAL","020933","BOEHRINGER INGELHEIM","09/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020636s050,020933s040lbl.pdf#page=19"
"Viramune XR","Nevirapine","TABLET, EXTENDED RELEASE;ORAL","201152","BOEHRINGER INGELHEIM","09/24/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201152s013lbl.pdf#page=18"
"Visicol","Sodium Phosphate, Dibasic Anhydrous; Sodium Phosphate, Monobasic, Monohydrate","TABLET;ORAL","021097","SALIX PHARMS","03/07/2013","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM134684.pdf"
"Vituz","Chlorpheniramine Maleate; Hydrocodone Bitartrate","SOLUTION;ORAL","204307","PERSION","06/28/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25"
"Vivactil","Protriptyline Hydrochloride","TABLET;ORAL","016012","TEVA WOMENS","07/17/2014","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf"
"Vivitrol","Naltrexone","FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","021897","ALKERMES","05/08/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021897s045lbl.pdf#page=32"
"Vogelxo","Testosterone","GEL;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204399s010lbl.pdf#page=22"
"Vogelxo","Testosterone","GEL, METERED;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23"
"Vogelxo","Testosterone","GEL, METERED;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204399s010lbl.pdf#page=22"
"Vogelxo","Testosterone","GEL;TRANSDERMAL","204399","UPSHER SMITH LABS","04/30/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23"
"Voltaren","Diclofenac Sodium","TABLET, DELAYED RELEASE;ORAL","019201","NOVARTIS","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089822.pdf"
"Voltaren Arthritis Pain","Diclofenac Sodium","GEL;TOPICAL","022122","GLAXOSMITHKLINE CONS","02/14/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22"
"Voltaren-XR","Diclofenac Sodium","TABLET, EXTENDED RELEASE;ORAL","020254","NOVARTIS","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501669.pdf"
"Votrient","Pazopanib Hydrochloride","TABLET;ORAL","022465","NOVARTIS","08/17/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022465s024s025lbl.pdf#page=26"
"Votrient","Pazopanib Hydrochloride","TABLET;ORAL","022465","NOVARTIS","08/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s030lbl.pdf#page=27"
"Votrient","Pazopanib Hydrochloride","TABLET;ORAL","022465","NOVARTIS","08/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s028lbl.pdf#page=27"
"Votrient","Pazopanib Hydrochloride","TABLET;ORAL","022465","NOVARTIS","08/17/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s029lbl.pdf#page=29"
"Vraylar","Cariprazine Hydrochloride","CAPSULE;ORAL","204370","ALLERGAN","05/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204370s006lbl.pdf#page=39"
"Vyvanse","Lisdexamfetamine Dimesylate","CAPSULE;ORAL","021977","TAKEDA PHARMS USA","07/31/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/ 021977s034,208510s002lbl.pdf#page=38"
"Vyvanse","Lisdexamfetamine Dimesylate","TABLET, CHEWABLE;ORAL","208510","TAKEDA PHARMS USA","07/31/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021977s034,208510s002lbl.pdf#page=38"
"Wellbutrin","Bupropion Hydrochloride","TABLET;ORAL","018644","GLAXOSMITHKLINE","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018644s054lbl.pdf#page=32"
"Wellbutrin SR","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","020358","GLAXOSMITHKLINE","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020358s061lbl.pdf#page=34"
"Wellbutrin XL","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021515","VALEANT INTL","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021515s036lbl.pdf#page=28"
"Wellbutrin XL","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","021515","VALEANT INTL","11/05/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021515s040lbl.pdf#page=28"
"Xanax","Alprazolam","TABLET;ORAL","018276","UPJOHN","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018276s052lbl.pdf#page=24"
"Xanax XR","Alprazolam","TABLET, EXTENDED RELEASE;ORAL","021434","UPJOHN","12/16/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021434s016lbl.pdf#page=24"
"Xarelto","Rivaroxaban","TABLET;ORAL","022406","JANSSEN PHARMS","03/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022406s027,202439s034lbl.pdf#page=60"
"Xarelto","Rivaroxaban","TABLET;ORAL","202439","JANSSEN PHARMS","03/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022406s027,202439s034lbl.pdf#page=60"
"Xarelto","Rivaroxaban","TABLET;ORAL","202439","JANSSEN PHARMS","03/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202439s031,022406s035lbl.pdf#page=60"
"Xarelto","Rivaroxaban","TABLET;ORAL","022406","JANSSEN PHARMS","03/10/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202439s031,022406s035lbl.pdf#page=60"
"Xartemis XR","Acetaminophen; Oxycodone Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","204031","MALLINCKRODT INC","09/18/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34"
"Xeljanz","Tofacitinib Citrate","TABLET;ORAL","203214","PF PRISM CV","12/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203214s023,208246s011lbl.pdf#page=52"
"Xeljanz XR","Tofacitinib Citrate","TABLET, EXTENDED RELEASE;ORAL","208246","PFIZER","12/12/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208246s009lbl.pdf#page=55"
"Xenazine","Tetrabenazine","TABLET;ORAL","021894","VALEANT PHARMS NORTH","09/13/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24"
"Xeomin","Incobotulinumtoxina","INJECTABLE; INJECTION","125360","MERZ PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s078lbl.pdf#page=21"
"Xeomin","Incobotulinumtoxina","INJECTABLE; INJECTION","125360","MERZ PHARMS","08/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125360s074lbl.pdf#page=19"
"Xgeva","Denosumab","INJECTABLE; SUBCUTANEOUS","125320","AMGEN","06/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125320s205lbl.pdf#page=30"
"Xgeva","Denosumab","INJECTABLE; SUBCUTANEOUS","125320","AMGEN","06/09/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125320s202lbl.pdf#page=30"
"Xiaflex","Collagenase Clostridium Histolyticum","SOLUTION; INJECTION","125338","AUXILIUM PHARMS","09/26/2018","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125338s0040mg.pdf"
"Xigduo XR","Dapagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205649","ASTRAZENECA AB","02/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205649s014lbl.pdf#page=52"
"Xigduo XR","Dapagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205649","ASTRAZENECA AB","02/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205649s013lbl.pdf#page=52"
"Xigduo XR","Dapagliflozin; METformin Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","205649","ASTRAZENECA AB","02/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205649s011lbl.pdf#page=52"
"Xolair","Omalizumab","VIAL","103976","GENENTECH","05/01/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103976s5234lbl.pdf#page=33"
"Xospata","Gilteritinib Fumarate","TABLET;ORAL","211349","ASTELLAS","05/29/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211349s001lbl.pdf#page=18"
"Xpovio","Selinexor","TABLET;ORAL","212306","KARYOPHARM THERAPS","06/22/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212306s001lbl.pdf#page=24"
"Xtampza ER","Oxycodone","CAPSULE, EXTENDED RELEASE;ORAL","208090","COLLEGIUM PHARM INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208090s012lbl.pdf#page=38"
"Xultophy 100/3.6","Insulin Degludec; Liraglutide","SOLUTION;SUBCUTANEOUS","208583","NOVO","11/15/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208583s014s015lbl.pdf#page=40"
"Xyosted (Autoinjector)","Testosterone Enanthate","SOLUTION;SUBCUTANEOUS","209863","ANTARES PHARMA INC","11/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16"
"Xyrem","Sodium Oxybate","SOLUTION;ORAL","021196","JAZZ PHARMS","07/21/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021196s033s034lbl.pdf#page=27"
"Xyrem","Sodium Oxybate","SOLUTION;ORAL","021196","JAZZ PHARMS","07/21/2020","http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021196s030lbl.pdf#page=26"
"Yervoy","Ipilimumab","INJECTABLE; INJECTION","125377","BRISTOL MYERS SQUIBB","08/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125377s111lbl.pdf#page=55"
"Yondelis","Trabectedin","POWDER;INTRAVENOUS","207953","JANSSEN PRODS","06/03/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207953s004lbl.pdf#page=20"
"Yosprala","Aspirin; Omeprazole","TABLET, DELAYED RELEASE;ORAL","205103","GENUS LIFESCIENCES","06/07/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf#page=37"
"Yupelri","Revefenacin","SOLUTION;INHALATION","210598","MYLAN IRELAND LTD","05/21/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf#page=16"
"Zarontin","Ethosuximide","CAPSULE;ORAL","012380","PARKE DAVIS","05/17/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf"
"Zegerid","Omeprazole; Sodium Bicarbonate","FOR SUSPENSION;ORAL","021636","SALIX","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021636s020,021849s015lbl.pdf#page=30"
"Zegerid","Omeprazole; Sodium Bicarbonate","CAPSULE;ORAL","021849","SALIX","09/24/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021636s020,021849s015lbl.pdf#page=30"
"Zelboraf","Vemurafenib","TABLET;ORAL","202429","HOFFMANN LA ROCHE","05/18/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21"
"Zenpep","Pancrelipase (Amylase;Lipase;Protease)","CAPSULE, DELAYED RELEASE;ORAL","022210","ZENPEP","03/20/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf"
"Zerit","Stavudine","CAPSULE;ORAL","020412","BRISTOL MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29"
"Zerit","Stavudine","FOR SOLUTION;ORAL","020413","BRISTOL-MYERS SQUIBB","12/17/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29"
"Ziagen","Abacavir Sulfate","TABLET;ORAL","020977","VIIV HLTHCARE","05/09/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020977s033s034,020978s036s037lbl.pdf#page=27"
"Ziagen","Abacavir Sulfate","SOLUTION;ORAL","020978","VIIV HLTHCARE","05/09/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020977s033s034,020978s036s037lbl.pdf#page=27"
"Zinbryta","Daclizumab","INJECTABLE;INJECTION","761029","BIOGEN","11/01/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24"
"Zipsor","Diclofenac Potassium","CAPSULE;ORAL","022202","ASSERTIO","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM243355.pdf"
"Zohydro ER","Hydrocodone Bitartrate","CAPSULE, EXTENDED RELEASE;ORAL","202880","PERSION","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202880s019lbl.pdf#page=29"
"Zoloft","Sertraline Hydrochloride","TABLET;ORAL","019839","UPJOHN","12/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019839s091lbl.pdf#page=27"
"Zoloft","Sertraline Hydrochloride","CONCENTRATE;ORAL","020990","UPJOHN","12/08/2017","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019839s091lbl.pdf#page=27"
"Zolpidem Tartrate","Zolpidem Tartrate","TABLET;ORAL","076062","STRIDES PHARMA","04/23/2007","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf"
"Zolpimist","Zolpidem Tartrate","SPRAY, METERED;ORAL","022196","AYTU","08/18/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19"
"Zonegran","Zonisamide","CAPSULE;ORAL","020789","SUNOVION PHARMS INC","04/13/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25"
"Zonegran","Zonisamide","CAPSULE;ORAL","020789","SUNOVION PHARMS INC","04/13/2020","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM152828.pdf"
"Zontivity","Vorapaxar Sulfate","TABLET;ORAL","204886","TOPROL","11/07/2019","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf"
"Zortress","Everolimus","TABLET;ORAL","021560","NOVARTIS","08/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021560Orig1s022lbl.pdf#page=31"
"Zortress","Everolimus","TABLET;ORAL","021560","NOVARTIS","08/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021560s021lbl.pdf#page=32"
"Zorvolex","Diclofenac","CAPSULE;ORAL","204592","ZYLA","05/09/2016","http://www.fda.gov/downloads/Drugs/DrugSafety/UCM372061.pdf"
"Zubsolv","Buprenorphine Hydrochloride; Naloxone Hydrochloride","TABLET;SUBLINGUAL","204242","OREXO US INC","10/07/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204242s017lbl.pdf#page=18"
"Zulresso","Brexanolone","SOLUTION;INTRAVENOUS","211371","SAGE THERAP","12/13/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211371s002lbl.pdf#page=20"
"Zurampic","Lesinurad","TABLET;ORAL","207988","IRONWOOD PHARMS INC","08/04/2016","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17"
"Zutripro","Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride","SOLUTION;ORAL","022439","PERSION","06/28/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28"
"Zyban","Bupropion Hydrochloride","TABLET, EXTENDED RELEASE;ORAL","020711","GLAXOSMITHKLINE","07/19/2019","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020711s048lbl.pdf#page=37"
"Zydelig","Idelalisib","TABLET;ORAL","205858","GILEAD SCIENCES INC","10/10/2018","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205858s011lbl.pdf#page=1"
"Zyprexa","Olanzapine","TABLET;ORAL","020592","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
"Zyprexa","Olanzapine","INJECTABLE;INTRAMUSCULAR","021253","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf#page=37"
"Zyprexa","Olanzapine","TABLET;ORAL","020592","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf#page=37"
"Zyprexa","Olanzapine","INJECTABLE;INTRAMUSCULAR","021253","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf#page=37"
"Zyprexa","Olanzapine","TABLET;ORAL","020592","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf#page=37"
"Zyprexa","Olanzapine","INJECTABLE;INTRAMUSCULAR","021253","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"
"Zyprexa Relprevv","Olanzapine Pamoate","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","022173","ELI LILLY CO","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29"
"Zyprexa Relprevv","Olanzapine Pamoate","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","022173","ELI LILLY CO","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s034lbl.pdf#page=30"
"Zyprexa Relprevv","Olanzapine Pamoate","SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR","022173","ELI LILLY CO","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022173s030lbl.pdf#page=29"
"Zyprexa Zydis","Olanzapine","TABLET, ORALLY DISINTEGRATING;ORAL","021086","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf#page=37"
"Zyprexa Zydis","Olanzapine","TABLET, ORALLY DISINTEGRATING;ORAL","021086","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf#page=37"
"Zyprexa Zydis","Olanzapine","TABLET, ORALLY DISINTEGRATING;ORAL","021086","LILLY","04/23/2020","https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37"